Suggestive for eosinophilic asthma

ASTHMA_EOSINOPHIL_SUGG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions J10_ASTHMA	63265
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_NASALPOLYP M13_CHURGSTRAUSS J10_PULMEOS Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT	3870
6. Filter based on genotype QC (FinnGen only)	3752

Control definitions (FinnGen only)

Control conditions: not J10_ASTHMA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_EOSINOPHIL_SUGG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!J10_ASTHMA
SEX
INCLUDE	J10_NASALPOLYP\|M13_CHURGSTRAUSS\|J10_PULMEOS\|Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
PRE_CONDITIONS
CONDITIONS	J10_ASTHMA
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Suggestive for eosinophilic asthma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	21151	9574	11468
Only index persons	19226	8895	10331
Unadjusted period prevalence (%)
Whole population	0.30	0.27	0.32
Only index persons	0.36	0.33	0.39
Median age at first event (years)
Whole population	51.33	50.38	52.09
Only index persons	50.40	49.51	51.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3752	1857	1895
Unadjusted period prevalence (%)	0.76	0.66	0.87
Median age at first event (years)	50.40	48.30	52.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3870: Matched controls
38700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.9

317.3

462

649

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

40.1

313.3

191

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

3.7

313.0

2667

14540

J46

ICD-10 Finland

Status asthmaticus

161.5

307.7

518

R03AK06

ATC

salmeterol and fluticasone; inhalant

16.0

307.7

1651

1723

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

18.7

307.7

329

191

J31.0

ICD-10 Finland

Chronic rhinitis

5.9

307.7

717

1433

J33

ICD-10 Finland

Nasal polyp

35.6

307.7

247

R03AC12

ATC

salmeterol; inhalant

35.2

307.7

716

248

J33.8

ICD-10 Finland

Other polyp of sinus

155.6

307.7

1772

209

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

61.7

307.7

369

DPA30

NOMESCO Finland

Sphenotomy

74.0

307.7

332

R01AD58

ATC

fluticasone, combinations; nasal

4.4

307.7

1590

5269

J45.8

ICD-10 Finland

Mixed asthma

178.0

307.7

537

49300

ICD-8 Finland

Asthma, bronchiale

+∞

307.7

510

J33.0

ICD-10 Finland

Polyp of nasal cavity

172.7

307.7

2360

347

R03BA05

ATC

fluticasone; inhalant

10.8

307.7

1732

2708

TDM10

NOMESCO Finland

Puncture of maxillary antrum

25.7

307.7

950

483

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

107.3

307.7

184

J45.0

ICD-10 Finland

Predominantly allergic asthma

198.3

307.7

1723

156

J33.9

ICD-10 Finland

Nasal polyp, unspecified

47.2

307.7

559

138

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

21.8

307.7

1583

1191

R96

ICPC

Asthma

22.0

307.7

1230

804

J45

ICD-10 Finland

Asthma

31.9

307.7

1521

770

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

133.2

307.7

3256

1482

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

42.5

307.7

1765

749

R03DA04

ATC

theophylline; systemic, rectal

19.7

307.7

644

389

R01BA52

ATC

pseudoephedrine, combinations; oral

3.7

307.7

1804

7340

J45.1

ICD-10 Finland

Nonallergic asthma

261.1

307.7

1454

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

37.6

307.7

270

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

147.8

307.7

223

R01AD09

ATC

mometasone; nasal

7.7

307.7

2971

11656

R01AD01

ATC

beclometasone; nasal

6.6

307.7

1409

3071

H02AB07

ATC

prednisone; oral

7.4

307.7

1295

2460

J32.4

ICD-10 Finland

Chronic pansinusitis

84.2

307.7

814

122

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

63.6

307.7

1287

301

ZXA10

NOMESCO Finland

Bilateral

4.7

307.7

1391

4121

H02AB04

ATC

methylprednisolone; systemic

8.6

307.7

1471

2588

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

17.5

307.7

783

553

XQ800

NOMESCO Finland

Prick test

7.2

307.7

600

966

R03AK08

ATC

formoterol and beclometasone; inhalant

33.0

307.7

637

230

R03BA02

ATC

budesonide; inhalant

14.8

307.7

1924

2429

R06AE07

ATC

cetirizine; oral

3.7

307.7

2297

10991

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

17.9

307.7

567

368

R01AD05

ATC

budesonide; nasal

11.9

307.7

1058

1185

R03DC01

ATC

zafirlukast; oral

39.7

307.7

253

R03AC13

ATC

formoterol; inhalant

24.8

307.7

699

341

UDM02

NOMESCO Finland

Sinoscopy

19.0

307.7

504

303

R03BA08

ATC

ciclesonide; inhalant

10.7

307.7

855

995

4222

FHL

Endonasal etmoidectomy

75.8

307.7

352

UDH02

NOMESCO Finland

Rhinopharyngoscopy

17.5

307.7

1304

1095

R01AD12

ATC

fluticasone furoate; nasal

4.2

307.7

1902

7310

J01.0

ICD-10 Finland

Acute maxillary sinusitis

4.8

307.7

1641

5108

R03BA01

ATC

beclometasone; inhalant

13.2

307.7

1494

1765

R03AC02

ATC

salbutamol; inhalant

21.7

307.7

3561

13406

R03AK11

ATC

formoterol and fluticasone; inhalant

25.3

307.7

345

149

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

17.5

307.7

286

176

R03AC03

ATC

terbutaline; inhalant

9.5

307.7

1275

1911

H02AB06

ATC

prednisolone; systemic

21.8

307.7

3508

11903

DHB20

NOMESCO Finland

Polypectomy of internal nose

114.6

307.7

1171

146

R03AK07

ATC

formoterol and budesonide; inhalant

9.2

307.7

1884

3606

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

14.8

307.7

407

305

R01AD08

ATC

fluticasone; nasal

21.5

307.7

3155

6594

XG474

NOMESCO Finland

Exhalation nntrogen oxide

25.4

307.7

314

134

R03BB04

ATC

tiotropium bromide; inhalant

12.2

307.7

1091

1202

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

117.5

307.7

343

J45.9

ICD-10 Finland

Asthma, unspecified

177.9

307.7

3150

929

R03DC03

ATC

montelukast; oral

25.8

307.7

2277

2033

R06AX27

ATC

desloratadine; oral

3.5

306.3

1578

6289

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.4

300.7

413

541

R01AD11

ATC

triamcinolone; nasal

5.1

280.6

678

1558

J01FA10

ATC

azithromycin; systemic

3.4

264.1

2711

15856

DHB50

NOMESCO Finland

Turbinoplasty

9.4

263.7

327

376

J01AA02

ATC

doxycycline; systemic

5.7

256.2

3519

24607

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

105.1

256.2

132

4224

FHL

Endonasal anthrostomy

20.0

249.7

194

102

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

4.4

249.1

725

1924

J01FA06

ATC

roxithromycin; oral

3.0

248.8

2022

10245

R06AE09

ATC

levocetirizine; oral

3.9

248.4

895

2773

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

247.6

235

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.6

245.0

1065

3735

J34.2

ICD-10 Finland

Deviated nasal septum

5.5

239.3

503

1018

J01FA09

ATC

clarithromycin; systemic

3.0

238.6

1637

7511

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

17.2

230.3

192

117

H65.3

ICD-10 Finland

Chronic mucoid otitis media

12.3

229.4

232

199

J30.3

ICD-10 Finland

Other allergic rhinitis

8.4

228.9

310

397

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.7

215.3

315

441

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

52.9

215.2

123

R06AX13

ATC

loratadine; oral

3.6

213.9

852

2801

DJD20

NOMESCO Finland

Plastic repair of septum of nose

6.3

209.8

377

656

D72.1

ICD-10 Finland

Eosinophilia

45.3

208.2

123

R06AX22

ATC

ebastine; oral

3.4

208.0

954

3424

DHA10

NOMESCO Finland

Biopsy of cavity of nose

19.1

202.5

160

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

106.8

202.0

104

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

689.9

201.2

197

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

17.2

198.3

165

100

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.9

197.6

1352

6075

R06.2

ICD-10 Finland

Wheezing

7.2

196.7

306

458

XG410

NOMESCO Finland

Flow-volume spirometry

7.0

195.7

310

473

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

19.1

191.2

151

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

91.4

187.0

R02

ICPC

Shortness of breath/dyspnoea

3.6

185.5

719

2306

4226

FHL

Posterior radical surgery and possible etmoidectomy

18.9

184.1

146

J01MA14

ATC

moxifloxacin; systemic

4.0

183.0

584

1639

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

5.9

180.5

341

621

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.1

180.4

555

1516

J47

ICD-10 Finland

Bronchiectasis

12.3

178.6

180

153

J32.8

ICD-10 Finland

Other chronic sinusitis

26.4

178.0

123

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.3

173.2

369

750

R06.0

ICD-10 Finland

Dyspnoea

2.7

173.0

1274

5880

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

172.2

164

J01FA15

ATC

telithromycin; oral

3.7

170.5

614

1869

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

165.3

1216

5588

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

24.6

164.9

117

R06AX26

ATC

fexofenadine; oral

4.5

163.7

440

1083

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

161.6

154

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

31.7

152.4

J01DA06

ATC

[U] cefuroxime

3.0

151.0

795

3042

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

9.6

148.6

178

194

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.4

148.4

396

967

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

147.9

141

DMB10

NOMESCO Finland

Radical maxillary antrotomy

21.1

147.3

111

C01CA24

ATC

epinephrine; parenteral

4.6

146.3

370

866

J01.4

ICD-10 Finland

Acute pansinusitis

16.2

145.0

124

ZXC95

NOMESCO Finland

Use of surgical navigator

10.6

143.2

159

156

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

138.7

2060

12779

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

20.3

137.1

105

J32.1

ICD-10 Finland

Chronic frontal sinusitis

17.9

135.6

110

4239

FHL

Other measure in this category

23.7

134.9

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

49.7

134.7

R03BB01

ATC

ipratropium bromide; inhalant

6.6

133.3

221

352

J01.1

ICD-10 Finland

Acute frontal sinusitis

8.6

129.9

168

202

J01CA04

ATC

amoxicillin; systemic

3.0

129.1

3339

26075

D11AH05

ATC

dupilumab; topical

169.4

125.2

131

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

28.3

123.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.7

123.0

435

1296

H65.2

ICD-10 Finland

Chronic serous otitis media

9.6

120.3

143

154

R03BC01

ATC

cromoglicic acid; inhalant

11.9

114.7

117

101

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.6

113.9

147

176

395

Kela drug reimbursment

Dupilumab

136.4

111.7

119

R03BC03

ATC

nedocromil; inhalant

3.8

110.2

365

1038

J20

ICD-10 Finland

Acute bronchitis

3.1

109.7

511

1802

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

107.8

103

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

105.9

1890

12165

DPA20

NOMESCO Finland

Trephine of frontal sinus

45.0

104.7

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

104.6

100

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

9.6

104.6

124

133

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

4.6

103.9

257

588

XG405

NOMESCO Finland

Education on PEF monitoring

10.7

103.5

113

108

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

19.2

100.6

J01DC02

ATC

cefuroxime; systemic

3.8

98.8

326

923

R03AC04

ATC

fenoterol; inhalant

42.8

98.4

ZXD20

NOMESCO Finland

Day surgery

2.6

98.1

648

2745

Z3231

NOMESCO Finland

Registered nurse

2.2

97.5

1201

6675

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

253.9

97.1

A02BC02

ATC

pantoprazole; systemic

2.1

96.1

2774

20967

J33.1

ICD-10 Finland

Polypoid sinus degeneration

167.5

93.6

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.3

93.3

249

604

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.3

93.2

194

383

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

93.0

1617

10168

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.7

92.7

224

502

J01DB01

ATC

cefalexin; oral

2.6

92.6

3312

27069

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

92.1

507

1953

A07AA02

ATC

nystatin; oral

3.7

91.5

312

902

ZXE00

NOMESCO Finland

One hour or less

2.0

91.0

1622

10267

H66.0

ICD-10 Finland

Acute suppurative otitis media

3.4

90.8

350

1096

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.2

90.0

189

376

Z51.6

ICD-10 Finland

Desensitization to allergens

14.5

89.6

Z2221

NOMESCO Finland

Medical doctor

2.1

89.6

1180

6690

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

87.9

423

1512

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

41.3

87.6

SPAT1058

SPAT

PEF monitoring instruction

3.2

87.2

380

1282

DHB40

NOMESCO Finland

Conchotomy

24.2

87.0

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

86.0

988

5304

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

5.9

86.0

158

278

R03DX09

ATC

mepolizumab; parenteral

+∞

85.7

J32

ICD-10 Finland

Chronic sinusitis

10.8

85.7

R09

ICPC

Sinus symptom/complaint

3.0

85.4

404

1429

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

85.1

1516

9537

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

6.8

84.9

134

202

J01

ICD-10 Finland

Acute sinusitis

3.6

83.5

289

843

WX002

NOMESCO Finland

Sedation and analgesia

2.2

83.1

885

4603

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.9

83.0

256

690

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

82.9

799

3991

3028

Kela drug reimbursment

Mepolizumab

+∞

82.6

J01DA01

ATC

[U] cefalexin

1.9

80.3

2446

18236

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

79.9

402

1470

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

209.4

79.6

J01MA12

ATC

levofloxacin; systemic

2.2

79.5

832

4288

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

79.1

1132

6565

A01AB09

ATC

miconazole; local oral

2.9

78.6

393

1432

297, ,

Kela drug reimbursment

+∞

77.3

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.1

74.8

162

331

UDC00

NOMESCO Finland

Ear microscopy

2.9

73.4

384

1433

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

21.9

72.8

SPAT1059

SPAT

Spirometry at the office

3.6

72.8

247

710

TGC00

NOMESCO Finland

Bronchial lavation

4.9

72.5

162

340

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

11.8

71.4

R74

ICPC

Upper respiratory infection acute

1.9

71.1

1177

7131

R03BB07

ATC

umeclidinium bromide; inhalant

12.3

70.3

R05

ICPC

Cough

2.0

69.5

945

5343

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.1

69.4

198

504

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

16.2

69.3

J01MA02

ATC

ciprofloxacin; systemic

1.8

69.1

1588

10658

50501

ICD-8 Finland

Nasal polyp, Maxillaris

31.8

67.6

A02BC05

ATC

esomeprazole; systemic

1.8

66.7

1619

11012

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

65.8

1299

8288

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.2

65.3

112

184

R01AD

ATC

Corticosteroids

7.6

64.1

122

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.9

64.0

198

534

ZXC60

NOMESCO Finland

Application of heat

5.6

63.7

122

223

R01AC01

ATC

cromoglicic acid; nasal

4.1

63.7

183

468

R01AD59

ATC

mometasone, combinations; nasal

3.6

62.9

213

611

50304

ICD-8 Finland

Chronic sinusitis, Ethmoidalis

87.9

62.1

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

6.1

61.7

108

181

G47.3

ICD-10 Finland

Sleep apnoea

1.9

61.7

957

5631

A01AB04

ATC

amphotericin B; local oral

3.5

61.1

220

657

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.1

60.7

265

891

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.9

60.6

187

503

H66.9

ICD-10 Finland

Otitis media, unspecified

3.1

60.2

273

938

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.5

59.9

147

333

R75

ICPC

Sinusitis acute/chronic

3.3

59.7

235

742

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

59.7

312

1160

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.4

58.6

470

2149

N02AX02

ATC

tramadol; systemic, rectal

1.7

58.5

1689

11944

J02AC01

ATC

fluconazole; systemic

1.8

58.1

1430

9663

J01DA08

ATC

[U] cefaclor

2.4

57.6

427

1884

N02BE01

ATC

paracetamol; systemic, rectal

2.3

57.5

3443

30141

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

57.4

1750

12544

A02BC01

ATC

omeprazole; systemic

1.8

57.3

1060

6575

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

57.0

567

2832

R03DX10

ATC

benralizumab; systemic

+∞

56.4

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.8

56.2

127

269

R05

ICD-10 Finland

Cough

1.9

55.9

833

4814

4211

FHL

Transeptal septal resection and reconstruction

7.6

55.6

106

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

55.5

254

877

H02AB09

ATC

hydrocortisone; systemic

4.6

54.9

134

302

50708

ICD-8 Finland

Hay fever, Alia definita

12.2

54.0

3027

Kela drug reimbursment

Benralizumab

+∞

53.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

53.2

1641

11724

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

52.2

1122

7243

251, ,

Kela drug reimbursment

+∞

52.2

R07

ICPC

Sneezing/nasal congestion

2.8

51.7

274

1025

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.8

50.5

156

420

J01FF01

ATC

clindamycin; systemic

1.8

50.4

1070

6873

J30.0

ICD-10 Finland

Vasomotor rhinitis

4.0

50.3

144

367

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

6.6

49.7

123

DHB10

NOMESCO Finland

Excision of lesion of internal nose

13.2

49.4

SPAT1057

SPAT

Peak expiratory flow measurement

5.1

48.5

102

203

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

6.2

48.2

137

50499

ICD-8 Finland

Deflected nasal septum

4.8

47.9

109

232

T78.4

ICD-10 Finland

Allergy, unspecified

3.2

47.5

194

626

R06AX12

ATC

terfenadine; oral

3.1

47.3

211

717

R81

ICPC

Pneumonia

3.4

47.2

173

522

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

7.0

47.0

105

Z3226

NOMESCO Finland

Physiotherapist

1.9

47.0

715

4136

A02BC03

ATC

lansoprazole; oral

1.7

46.8

1091

7168

M05BA04

ATC

alendronic acid; oral

2.4

46.4

345

1519

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

46.3

875

5410

E0000UV, ,

ATC

1.6

45.4

1504

10816

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

45.2

935

5930

R4110

NOMESCO Finland

Physiotherapy

1.7

44.8

1057

6952

H65.0

ICD-10 Finland

Acute serous otitis media

4.8

44.4

102

219

A03

ICPC

Fever

1.9

44.4

608

3392

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

44.4

1304

9086

R03CC02

ATC

salbutamol; systemic

3.3

44.0

172

540

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

43.8

R08

ICPC

Nose symptom/complaint other

3.3

43.7

169

527

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

43.4

2661

22119

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.3

43.2

112

265

50709

ICD-8 Finland

Hay fever, Unspecified

9.2

42.2

R01BA01

ATC

phenylpropanolamine; oral

2.7

42.0

245

961

UJF32

NOMESCO Finland

Coloscopy

1.7

41.9

993

6519

R03DA05

ATC

aminophylline; systemic, rectal

9.4

41.9

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

41.8

256

1029

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

41.7

ZX112

NOMESCO Finland

Subcutaneous

3.9

41.6

125

330

R06AX18

ATC

acrivastine; oral

3.6

39.7

134

383

D07AC01

ATC

betamethasone; topical

1.6

39.6

1344

9640

ZXA05

NOMESCO Finland

Left side

1.7

39.1

922

6030

Z71.8

ICD-10 Finland

Other specified counselling

1.6

39.0

1099

7525

R01AC07

ATC

nedocromil; nasal

11.2

38.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

38.8

1014

6811

I45.9

ICD-10 Finland

Conduction disorder, unspecified

7.7

38.6

R01AC02

ATC

levocabastine; nasal

3.6

38.3

127

359

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

8.4

37.7

R29

ICPC

Respiratory symptom/complaint other

2.4

37.7

266

1142

M79.6

ICD-10 Finland

Pain in limb

1.6

36.8

1507

11238

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

36.4

490

2705

R06.5

ICD-10 Finland

Mouth breathing

2.1

36.2

370

1853

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

12.6

35.8

J01DA09

ATC

[U] cefadroxil

1.6

35.8

961

6478

SPAT1325

SPAT

Vaccination

1.6

35.7

1170

8276

D07AC13

ATC

mometasone; topical

1.6

35.5

1057

7307

4738X

ICD-9 Finland

Chronic sinusitis, Other chronic sinusitis

67.3

35.0

50509

ICD-8 Finland

Nasal polyp, Unspecified

96.0

34.8

ZXA00

NOMESCO Finland

Right side

1.6

34.6

974

6635

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

34.2

323

1568

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

34.2

412

2189

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.4

34.0

124

373

WX402

NOMESCO Finland

General anaesthesia

1.7

33.7

794

5164

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

33.4

145

485

L20.0

ICD-10 Finland

Besnier prurigo

2.4

33.3

244

1065

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

9.6

33.3

H01

ICPC

Ear pain/earache

2.0

33.0

393

2078

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.0

32.7

149

512

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

32.7

801

5258

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

32.3

554

3294

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

8.0

32.0

R05CB01

ATC

acetylcysteine; inhalant, oral

5.0

31.9

137

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

31.6

302

1472

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

31.5

737

4776

R03

ICPC

Wheezing

5.7

31.3

103

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

30.9

1040

7355

R51.80

ICD-10 Finland

Headache

1.8

30.8

530

3152

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

30.7

147

520

R60.0

ICD-10 Finland

Localized oedema

1.9

30.6

441

2482

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

30.5

668

4251

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

30.3

362

1914

L17

ICPC

Foot/toe symptom/complaint

1.6

29.9

1016

7194

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

29.8

425

2384

R01AX03

ATC

ipratropium bromide; nasal

3.4

29.8

106

314

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

11.6

29.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

28.8

1004

7141

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

28.3

372

2030

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

28.1

231

1059

1210

FHL

Anthroscopy

10.4

28.0

R50.9

ICD-10 Finland

Fever, unspecified

1.7

28.0

533

3258

GD1AA, ,

SPAT

1.8

27.8

420

2398

S18

ICPC

Laceration/cut

1.5

27.7

1638

12950

R03BA07

ATC

mometasone; inhalant

6.5

27.7

R83

ICPC

Respiratory infection other

1.6

27.5

826

5670

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

5.8

27.1

WZC30

NOMESCO Finland

Teaching

1.7

27.1

583

3684

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

27.0

277

1386

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

26.9

702

4658

GX1C5, ,

SPAT

9.8

26.8

A46

ICD-10 Finland

Erysipelas

1.7

26.6

523

3222

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

26.6

361

1990

R49.01

ICD-10 Finland

Functional dysphonia

3.0

26.5

119

406

R49.08

ICD-10 Finland

Other specified dysphonia

3.4

26.4

279

SPAT1036

SPAT

Maxillary puncture

10.4

26.2

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

6.4

26.1

D07AB08

ATC

desonide; topical

1.9

26.0

372

2087

WQ000

NOMESCO Finland

Hyposensibilisation

9.0

25.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

25.8

571

3629

J01FA01

ATC

erythromycin; systemic

1.8

25.6

450

2684

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

8.7

25.4

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

5.3

25.1

E000002, ,

ATC

1.9

24.9

362

2039

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

24.7

548

3484

L04AX01

ATC

azathioprine; systemic

2.4

24.6

167

704

A01AB10

ATC

natamycin; local oral

3.0

24.4

110

376

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

24.4

880

6269

D07AA02

ATC

hydrocortisone; topical

1.7

24.3

450

2725

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.6

24.2

R04.2

ICD-10 Finland

Haemoptysis

2.7

24.0

132

503

J02AC02

ATC

itraconazole; systemic

1.6

23.9

625

4137

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.0

23.9

104

349

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

23.8

134

516

DPB00

NOMESCO Finland

Partial excision of frontal sinus

31.2

23.7

P01AB01

ATC

metronidazole; oral, rectal

1.4

23.6

1351

10526

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

23.4

586

3839

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

23.2

1448

11450

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

23.2

595

3920

R05CB02

ATC

bromhexine; systemic

4.0

23.1

164

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

23.1

333

1870

DM1AI, ,

SPAT

5.7

22.9

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

231.3

22.6

K02.1

ICD-10 Finland

Caries of dentine

1.4

22.5

2048

17247

L50.9

ICD-10 Finland

Urticaria, unspecified

2.6

22.4

135

538

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

3.6

22.3

210

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

22.2

1135

8638

R03AC19

ATC

olodaterol

9.1

22.1

M25.5

ICD-10 Finland

Pain in joint

1.4

21.8

1079

8156

J98.1

ICD-10 Finland

Pulmonary collapse

6.4

21.8

XQ820

NOMESCO Finland

Exposure to medicinal substance

8.1

21.8

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

21.7

2536

22218

R01AD04

ATC

flunisolide; nasal

5.4

21.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

21.5

327

1867

R95

ICPC

Chron obstructive pulmonary disease

2.9

21.3

102

361

DM1QA, ,

SPAT

2.6

21.3

127

504

L50.8

ICD-10 Finland

Other urticaria

3.4

21.2

227

A02BA02

ATC

ranitidine; systemic

1.6

21.1

643

4399

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

21.1

622

4224

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

21.1

1243

9688

49099

ICD-8 Finland

Bronchitis, unspecified

4.7

21.0

103

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

20.9

226

1151

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

20.8

1622

13249

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.7

20.8

104

C03CA01

ATC

furosemide; systemic

1.5

20.5

930

6901

XQ802

NOMESCO Finland

Epicutan test

2.4

20.4

143

612

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

20.3

1935

16306

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.5

20.3

199

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

20.2

262

1421

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

20.2

1001

7551

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

20.1

708

4995

4618A

ICD-9 Finland

Acute sinusitis, Other acute sinusitis

16.1

20.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

20.0

431

2713

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

19.8

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.7

754

5407

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

19.5

842

6182

H26.3

ICD-10 Finland

Drug-induced cataract

5.8

19.3

R21

ICPC

Throat symptom/complaint

1.5

19.3

607

4178

Z01.7

ICD-10 Finland

Laboratory examination

1.6

19.2

496

3261

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

31.4

19.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

19.2

628

4357

J01DC04

ATC

cefaclor; oral

4.1

19.2

128

J01.8

ICD-10 Finland

Other acute sinusitis

5.9

19.1

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

18.9

200

1011

R42

ICD-10 Finland

Dizziness and giddiness

1.5

18.8

733

5270

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.1

18.8

N05BB01

ATC

hydroxyzine; systemic

2.0

18.8

202

1027

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

18.8

356

2164

49308

ICD-8 Finland

Asthma, Alia definita

+∞

18.8

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.9

18.7

293

4225

FHL

Exploratory buccal opening, includes polyps and cyst removal

7.0

18.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

18.6

310

1818

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

18.5

1317

10546

R97

ICPC

Allergic rhinitis

3.4

18.3

188

C07AB07

ATC

bisoprolol; oral

1.4

18.3

1652

13721

H70.1

ICD-10 Finland

Chronic mastoiditis

7.9

18.3

R06AX11

ATC

astemizole; oral

2.7

18.2

100

381

344

Kela drug reimbursment

Omalizumab

25.1

18.2

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.7

18.2

ZXC99

NOMESCO Finland

Other special technic in surgery

14.4

18.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

17.9

2273

19849

R2110

NOMESCO Finland

Giving the first information

1.9

17.9

220

1172

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

17.9

897

6757

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

17.9

563

3869

R78

ICPC

Acute bronchitis/bronchiolitis

3.1

17.9

252

M54.5

ICD-10 Finland

Low back pain

1.4

17.9

1170

9226

XG466

NOMESCO Finland

Sleep oxymetry

2.5

17.8

113

462

SFA20

NOMESCO Finland

Two-surface restoration

1.3

17.8

2026

17402

SFA10

NOMESCO Finland

One-surface restoration

1.3

17.8

1875

15920

E000003, ,

ATC

2.2

17.8

149

689

D07AD01

ATC

clobetasol; topical

1.5

17.8

564

3883

L03

ICPC

Low back symptom/complaint

1.4

17.8

888

6685

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.5

17.7

R03DB04

ATC

theophylline and adrenergics; systemic

22.9

17.7

A92

ICPC

Allergy/allergic reaction NOS

2.8

17.7

313

R03CC03

ATC

terbutaline; systemic

3.4

17.5

184

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

17.4

571

3957

E000001, ,

ATC

1.5

17.4

619

4363

M03BX02

ATC

tizanidine; oral

1.3

17.4

2161

18772

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.4

1396

11362

Z2446

NOMESCO Finland

Social worker

1.9

17.4

208

1099

K07

ICPC

Swollen ankles/oedema

2.2

17.3

152

717

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

17.3

1491

12267

R06AE08, ,

ATC

4.4

17.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

17.0

126

554

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

16.9

828

6201

SPAT1254

SPAT

Administration of medicine

1.6

16.9

448

2961

R03DX05

ATC

omalizumab; parenteral

25.7

16.9

A98

ICPC

Health maint/preventive medicine

1.9

16.8

3667

35071

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.9

16.8

272

49309

ICD-8 Finland

Asthma, Unspecified

+∞

16.7

C09CA06

ATC

candesartan; oral

1.4

16.5

782

5822

N03AX12

ATC

[U] gabapentin; oral

1.5

16.4

532

3675

X58

ICD-10 Finland

Exposure to other specified factors

1.6

16.3

464

3114

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

16.2

2366

20943

R43.0

ICD-10 Finland

Anosmia

4.3

16.2

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.2

16.1

199

J01CA02

ATC

pivampicillin; oral

2.4

16.1

109

460

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

16.1

363

2307

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

16.0

280

S21

ICPC

Skin texture symptom/complaint

1.5

15.9

467

3156

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.5

15.9

156

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

15.9

205

1111

DGW00

NOMESCO Finland

Dilatation of eustachian tube

12.3

15.8

N03AX16

ATC

[U] pregabalin

1.4

15.8

757

5642

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

15.7

277

48609

ICD-8 Finland

Pneumonia, unspecified

3.2

15.7

192

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

15.7

590

4200

EB1AA, ,

SPAT

1.8

15.7

228

1283

WW200

NOMESCO Finland

Immunization

2.5

15.7

405

SPAT1255

SPAT

Intravenous administration of medicine

1.8

15.7

235

1335

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

15.6

611

4382

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

15.6

326

2032

F2680, ,

NOMESCO Finland

26.4

15.6

L15

ICPC

Knee symptom/complaint

1.4

15.5

766

5735

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.0

15.5

230

C08DA01

ATC

verapamil; systemic

2.2

15.5

132

615

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

15.5

405

2667

J01MA01

ATC

ofloxacin; systemic

1.7

15.4

277

1658

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

15.4

327

2046

SFA30

NOMESCO Finland

Three-surface restoration

1.3

15.4

1461

12129

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.8

15.3

270

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

15.3

573

4075

M05BA07

ATC

risedronic acid; oral

2.5

15.3

374

H92.0

ICD-10 Finland

Otalgia

1.9

15.2

186

989

G04CA02

ATC

tamsulosin; oral

1.4

15.2

822

6249

N01

ICPC

Headache

1.7

15.2

299

1835

L50.0

ICD-10 Finland

Allergic urticaria

2.6

15.2

334

WX290

NOMESCO Finland

Other blockage of nerve

1.3

15.1

1520

12713

SPAT1263

SPAT

Sampling

1.3

15.0

1352

11128

D02AE01

ATC

carbamide; topical

1.9

15.0

206

1139

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.9

261

1551

EB1SA, ,

SPAT

2.0

14.9

173

905

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.8

395

2611

R13

ICD-10 Finland

Dysphagia

1.8

14.6

228

1310

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

14.6

157

799

DPB20

NOMESCO Finland

Obliteration of frontal sinus

+∞

14.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.5

281

1716

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

14.5

420

2828

L16

ICPC

Ankle symptom/complaint

1.6

14.5

355

2300

A02BC04

ATC

rabeprazole; oral

1.7

14.5

287

1764

K30

ICD-10 Finland

Functional dyspepsia

1.6

14.4

351

2272

R50

ICPC

Respiratory, Medication/prescr/renewal

15.4

14.4

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.6

14.3

133

H71

ICPC

Acute otitis media/myringitis

3.7

14.3

119

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.7

14.3

269

J01MA06

ATC

norfloxacin; oral

1.5

14.2

405

2716

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

14.2

725

5451

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.9

14.2

106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

14.2

422

2858

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

14.2

304

1907

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

14.2

176

942

R52.9

ICD-10 Finland

Pain, unspecified

1.6

14.1

306

1924

A07EA06

ATC

budesonide; oral, local oral

2.2

14.1

120

559

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

14.1

397

2658

GX1E5, ,

SPAT

4.0

14.0

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

14.0

201

K11.2

ICD-10 Finland

Sialoadenitis

2.2

13.9

116

537

N05CF01

ATC

zopiclone; oral

1.3

13.8

1029

8218

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

4.0

13.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

13.7

132

645

L12

ICPC

Hand/finger symptom/complaint

1.5

13.7

498

3514

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.4

13.7

147

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

13.5

558

4036

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.7

13.5

277

4212

FHL

Maxillapremmaxilla opening septum resection and reconstruction

4.7

13.5

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

13.5

152

787

D01BA02

ATC

terbinafine; oral

1.4

13.5

872

6810

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

13.5

421

2880

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.5

1256

10351

3DX05, ,

NOMESCO Finland

140.5

13.5

4718X

ICD-9 Finland

Nasal polyps, Other polyp of sinus

140.5

13.5

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

25.8

13.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

13.4

931

7355

A99

ICPC

Disease/condition unspecnature/site

1.6

13.3

300

1904

XG460

NOMESCO Finland

Short time oxymetry

3.1

13.3

180

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

13.3

2903

31014

J01X

ATC

OTHER ANTIBACTERIALS

4.9

13.3

S01GX02

ATC

levocabastine; ophthalmic

1.9

13.3

165

883

D19

ICPC

Teeth/gum symptom/complaint

1.4

13.3

878

6881

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.3

13.2

Y0499

ICD-8 Finland

Investigation of respiratory system

3.9

13.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

13.2

977

7785

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.2

933

7384

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.0

13.2

133

662

B37.0

ICD-10 Finland

Candidal stomatitis

3.8

13.1

103

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.4

13.1

396

L04AX03

ATC

methotrexate; systemic

1.6

13.0

311

2004

DC1AD

NOMESCO Finland

Temporalbone CT

3.4

13.0

137

L50.3

ICD-10 Finland

Dermatographic urticaria

2.9

12.9

210

4720A

ICD-9 Finland

Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA HYPERTROPHICA]

22.6

12.9

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

4.9

12.8

B01AC04

ATC

clopidogrel; oral

1.4

12.8

528

3816

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

12.8

406

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

12.8

387

2629

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

12.7

170

932

E000007, ,

ATC

1.9

12.7

157

839

H01.0

ICD-10 Finland

Blepharitis

1.8

12.7

202

1169

ZX120

NOMESCO Finland

Intravenous

1.6

12.6

306

1977

G50.1

ICD-10 Finland

Atypical facial pain

2.8

12.6

224

P06

ICPC

Sleep disturbance

1.5

12.6

350

2333

H29

ICPC

Ear symptom/complaint other

1.5

12.6

361

2425

C08DB01

ATC

diltiazem; oral

1.9

12.6

147

772

D11

ICPC

Diarrhoea

1.6

12.5

344

2288

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

12.5

203

1181

R04.0

ICD-10 Finland

Epistaxis

1.7

12.5

243

1486

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

9.3

12.5

DNW99

NOMESCO Finland

Other operation on ethmoidal sinus and bone

130.4

12.4

G44.2

ICD-10 Finland

Tension-type headache

1.5

12.4

395

2713

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

12.4

438

3073

N06AX11

ATC

mirtazapine; oral

1.3

12.3

1067

8681

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

12.3

185

1052

R03BB02

ATC

oxitropium bromide; inhalant

5.8

12.3

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

12.2

742

5727

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

12.2

211

1250

N06AX21

ATC

duloxetine; oral

1.5

12.1

351

2361

J05AH02

ATC

oseltamivir; oral

4.6

12.1

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

5.2

12.0

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

12.0

880

6989

KMAK, ,

NOMESCO Finland

1.3

11.9

1693

14668

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

11.9

226

1373

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.7

11.9

237

R12

ICD-10 Finland

Heartburn

1.7

11.9

240

1483

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

11.9

168

939

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

11.8

242

1500

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.1

11.8

156

A03FA02

ATC

cisapride; oral, rectal

1.7

11.8

220

1332

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

8.9

11.7

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

11.6

1176

9756

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

11.6

260

1648

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

11.6

246

1538

T78.3

ICD-10 Finland

Angioneurotic oedema

3.0

11.5

174

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

11.1

11.5

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.5

11.5

277

RK320, ,

NOMESCO Finland

3.8

11.4

I45.0

ICD-10 Finland

Right fascicular block

4.4

11.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.4

748

5839

D01

ICPC

Abdominal pain/cramps general

1.5

11.4

335

2263

E000006, ,

ATC

1.7

11.3

199

1184

U02

ICPC

Urinary frequency/urgency

1.5

11.3

410

2889

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

11.3

339

2298

R07.0

ICD-10 Finland

Pain in throat

1.7

11.3

199

1186

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.3

398

2790

4710A

ICD-9 Finland

Nasal polyps, Polyp of nasal cavity

35.1

11.3

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

35.1

11.3

R35

ICD-10 Finland

Polyuria

1.7

11.3

219

1340

N17

ICPC

Vertigo/dizziness

1.5

11.3

364

2507

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

11.2

436

3113

S51.8

ICD-10 Finland

Open wound of other parts of forearm

3.3

11.2

125

N06AB04

ATC

citalopram; systemic

1.4

11.2

625

4757

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.1

226

1398

B01AB05

ATC

enoxaparin; parenteral

1.3

11.1

1013

8279

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.1

11.1

146

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

11.1

207

1252

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.1

2064

18404

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

11.1

287

1884

J01AA04

ATC

lymecycline; systemic

1.5

11.1

381

2658

WX110, ,

SPAT

1.7

11.0

183

1072

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

11.0

325

S29

ICPC

Skin symptom/complaint other

1.4

11.0

593

4484

J05AB11

ATC

valaciclovir; oral

1.4

10.9

438

3145

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

10.9

315

2120

SPAT1260

SPAT

Consultation of another employee

1.4

10.9

534

3977

RK110, ,

NOMESCO Finland

4.1

10.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

10.9

332

2260

K51.5

ICD-10 Finland

Left sided colitis

2.1

10.8

443

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

10.8

181

J04.0

ICD-10 Finland

Acute laryngitis

2.1

10.7

451

U13

ICPC

Bladder symptom/complaint other

2.1

10.7

451

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.5

10.7

104

L01

ICPC

Neck symptom/complaint

1.4

10.7

452

3278

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.3

10.7

336

F29

ICPC

Eye symptom/complaint other

1.6

10.7

287

1900

L28

ICPC

Limited function/disability (L)

1.4

10.7

527

3928

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

10.6

388

B01AF02

ATC

apixaban; oral

1.5

10.6

387

2731

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

10.5

352

2440

DM1CI

NOMESCO Finland

Very extensive cone beam CT of paranasal sinus

8.5

10.5

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

10.5

163

937

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

10.5

450

3271

L12.0

ICD-10 Finland

Bullous pemphigoid

4.4

10.5

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

14.2

10.5

GX2C5

NOMESCO Finland

Short-lasting oximetry

4.6

10.5

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.0

10.4

157

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.1

10.4

136

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.0

10.4

152

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.4

190

1144

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

10.3

452

3298

J05AB01

ATC

aciclovir; systemic

1.3

10.3

667

5187

R49.03

ICD-10 Finland

Atrophic dysphonia

3.1

10.3

137

L95

ICPC

Osteoporosis

2.0

10.3

107

540

A04

ICPC

Weakness/tiredness general

1.4

10.3

411

2951

L30.3

ICD-10 Finland

Infective dermatitis

2.0

10.2

108

548

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

7.5

10.2

Z01.2

ICD-10 Finland

Dental examination

1.3

10.2

1434

12344

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

10.1

815

6538

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

10.1

272

1800

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

10.1

250

1623

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.1

10.1

422

A07EC02

ATC

mesalazine; oral, rectal

1.7

10.1

167

978

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

5.3

10.1

D09AB01

ATC

zinc bandage without supplements; topical

2.4

10.1

276

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

10.1

372

2630

C05AA08

ATC

fluocortolone; rectal, topical

1.4

10.0

431

3133

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

10.0

376

2666

DMW00

NOMESCO Finland

Intubation of maxillary antrum

8.4

10.0

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.6

10.0

207

1288

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

9.9

328

2268

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

9.9

112

582

WX722

NOMESCO Finland

PEEP

1.8

9.9

145

819

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

9.9

359

2531

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

9.9

105

535

DFF15

NOMESCO Finland

Speech audiometry

1.8

9.9

157

910

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

9.8

204

1270

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.0

9.8

141

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

9.8

335

2332

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

9.8

117

620

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

9.8

495

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.6

9.8

253

1660

XA420

NOMESCO Finland

Extensive sleep examination

3.1

9.8

131

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

4.0

9.8

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

9.8

256

1686

R04

ICPC

Breathing problem other

1.9

9.7

113

593

S22.3

ICD-10 Finland

Fracture of rib

1.6

9.7

228

1462

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.7

720

5706

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.5

9.7

R07.3

ICD-10 Finland

Other chest pain

1.5

9.7

308

2112

R25.2

ICD-10 Finland

Cramp and spasm

2.3

9.7

331

R49.09

ICD-10 Finland

Unspecified dysphonia

3.2

9.7

121

-1, ,

NOMESCO Finland

1.3

9.7

1007

8345

B37.08

ICD-10 Finland

Other candidal stomatitis

3.7

9.7

D02AX

ATC

Other emollients and protectives

2.1

9.7

403

R05CA10

ATC

expectorants - combinations

2.4

9.7

263

N06AX16

ATC

venlafaxine; oral

1.4

9.7

402

2906

R52.2

ICD-10 Finland

Other chronic pain

1.9

9.7

110

574

DHB30

NOMESCO Finland

Polypectomy of choana through maxillary antrum

55.1

9.6

50700, ,

ICD-8 Finland

55.1

9.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

9.6

250

1642

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

9.6

135

755

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.4

9.5

259

M79.1

ICD-10 Finland

Myalgia

1.4

9.5

419

3061

S01GX08

ATC

ketotifen; ophthalmic

1.9

9.5

119

642

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

9.4

255

1690

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

17.6

9.4

49330, ,

ICD-8 Finland

+∞

9.4

4223

FHL

Outeroid etomoidectomy

+∞

9.4

49320, ,

ICD-8 Finland

+∞

9.4

M48.0

ICD-10 Finland

Spinal stenosis

1.4

9.3

361

2575

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

9.3

227

1470

R43

ICPC

Respiratory, Other diagnostic procedure

4.0

9.3

XA421

NOMESCO Finland

Nocturnal polygraphy

4.9

9.3

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.2

9.3

109

R01AC03

ATC

azelastine; nasal

7.3

9.2

N02AC04

ATC

dextropropoxyphene; oral

2.0

9.1

508

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

9.1

248

1646

S16

ICPC

Bruise/contusion

2.0

9.1

440

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

9.1

120

658

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

11.5

9.1

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

36.8

9.0

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

9.0

490

3706

4451

FHL

Guitar cutting

2.4

9.0

266

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.5

8.9

224

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.9

1518

13284

E66.8

ICD-10 Finland

Other obesity

1.7

8.9

147

861

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

8.9

164

990

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

8.9

234

1542

ZXD35

NOMESCO Finland

Usual procedure

2.0

8.9

492

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.9

361

2599

UJH02

NOMESCO Finland

Anoscopy

1.8

8.8

125

700

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

8.8

716

5738

4781C

ICD-9 Finland

Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[CYSTA SINUS MAXILLARIS]

4.9

8.8

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

8.8

945

7848

S97

ICPC

Chronic ulcer skin

1.6

8.8

178

1102

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

8.8

206

1322

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.5

8.8

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.7

510

3899

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

8.7

145

852

N02BF01

ATC

gabapentin; oral

1.5

8.7

237

1574

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

8.7

370

2684

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.7

237

1575

H02

ICPC

Hearing complaint

1.4

8.7

414

3064

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

8.7

289

2003

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.6

8.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

8.6

222

1456

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.9

8.6

141

A01

ICPC

Pain general/multiple sites

1.5

8.6

253

1710

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.8

8.6

127

722

C09CA03

ATC

valsartan; oral

1.5

8.6

289

2008

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

8.6

170

1048

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

8.6

329

2344

R03AC18

ATC

indacaterol; inhalant

3.8

8.5

D01AC02

ATC

miconazole; topical

1.5

8.5

233

1551

DHW99

NOMESCO Finland

Other operation on nose

27.6

8.5

J01GB01

ATC

tobramycin; inhalant, parenteral

27.6

8.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

8.5

802

6556

D06

ICPC

Abdominal pain localized other

1.5

8.5

237

1584

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

8.5

285

1979

A97

ICPC

No disease

1.3

8.5

526

4059

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

20.1

8.5

J04BA02

ATC

dapsone; oral

3.9

8.4

L50.1

ICD-10 Finland

Idiopathic urticaria

3.6

8.4

4122

FHL

Tympanostomy (tympanic tube)

3.1

8.4

111

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

8.4

140

824

L50

ICD-10 Finland

Urticaria

2.5

8.4

213

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

8.4

175

1093

D06AX01

ATC

fusidic acid; topical

1.5

8.4

261

1785

DM1BI

NOMESCO Finland

Extensive cone beam CT of paranasal sinus

12.8

8.4

ZXC10

NOMESCO Finland

Use of laser

2.1

8.3

340

ZX109, ,

SPAT

4.7

8.3

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.3

694

5579

49310, ,

ICD-8 Finland

+∞

8.3

K80

ICPC

Cardiac arrhythmia NOS

1.5

8.3

240

1615

TDA90

NOMESCO Finland

Removal wax from ear

2.5

8.3

190

Z50.1

ICD-10 Finland

Other physical therapy

1.7

8.3

158

964

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

8.3

505

S02

ICPC

Pruritus

1.9

8.3

505

ZY010

NOMESCO Finland

Hospital outpatient

1.7

8.3

133

775

L20

ICPC

Joint symptom/complaint NOS

1.9

8.2

105

570

L04AA06

ATC

mycophenolic acid; systemic

2.3

8.2

277

J31.1

ICD-10 Finland

Chronic nasopharyngitis

3.2

8.2

102

K90.0

ICD-10 Finland

Coeliac disease

2.0

8.2

437

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

14.5

8.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.2

670

5373

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.0

8.1

459

A11

ICPC

Chest pain NOS

1.5

8.1

243

1650

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

8.1

181

1151

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

8.1

308

2192

XX9XW, ,

NOMESCO Finland

3.3

8.1

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

8.1

248

R28

ICPC

Limited function/disability (R)

2.8

8.1

141

6123

FHL

Radical surgery

1.9

8.0

532

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

8.0

532

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

8.0

221

1473

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.1

8.0

346

ZXD05

NOMESCO Finland

Urgent procedure

1.3

8.0

913

7628

G04CA01

ATC

alfuzosin; oral

1.4

8.0

415

3115

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.0

419

3150

J01DB05

ATC

cefadroxil; oral

1.7

8.0

129

753

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.1

8.0

104

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.9

8.0

120

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

7.9

135

799

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

7.9

285

2005

S01ED02

ATC

betaxolol; ophthalmic

3.4

7.9

D11AH01

ATC

tacrolimus; topical

3.4

7.9

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.0

7.9

443

XF402

NOMESCO Finland

ECG with work load test

1.4

7.9

320

2302

F2682, ,

NOMESCO Finland

13.0

7.9

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.9

7.9

500

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.6

7.9

160

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.9

342

2492

WVA20

NOMESCO Finland

Medicine administration

2.0

7.8

396

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

7.8

234

1587

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

7.8

156

964

R07.1

ICD-10 Finland

Chest pain on breathing

2.5

7.8

196

M02AA07

ATC

piroxicam; topical

1.2

7.8

1114

9537

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

7.7

657

5295

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

7.7

433

3291

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

7.7

184

1189

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

7.7

352

L28.1

ICD-10 Finland

Prurigo nodularis

3.3

7.6

315

Kela drug reimbursment

Clopidogrel

3.0

7.6

112

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.5

7.6

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.6

748

6133

207

Kela drug reimbursment

Chronic arrhythmias

1.3

7.6

453

3472

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

7.6

353

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.1

7.6

102

S01GX04

ATC

nedocromil; ophthalmic

2.4

7.6

199

4731A

ICD-9 Finland

Chronic sinusitis, Frontal

25.0

7.6

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.2

7.6

281

N03

ICPC

Pain face

3.1

7.5

4252

FHL

Resection, coagulation or cryo on the cortex and nasal mucosa

8.9

7.5

4227

FHL

Forehead cavity drainage

8.9

7.5

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

4.1

7.5

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.3

7.5

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

7.5

282

S81

ICD-10 Finland

Open wound of lower leg

4.2

7.5

R39

ICPC

Respiratory, Physical function test

3.7

7.5

R09.8

ICD-10 Finland

Other specified symptoms and signs involving the circulatory and respiratory systems

3.7

7.5

L18

ICPC

Muscle pain

1.8

7.4

115

663

M54

ICD-10 Finland

Dorsalgia

1.4

7.4

342

2516

S04

ICPC

Lump/swelling localized

1.4

7.4

293

2098

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

3.1

7.4

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.4

7.4

WX290, ,

SPAT

1.8

7.4

101

561

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.4

713

5832

L20

ICD-10 Finland

Atopic dermatitis

2.0

7.4

350

R03BB06

ATC

glycopyrronium bromide; inhalant

6.5

7.4

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

7.4

475

R51

ICD-10 Finland

Headache

1.7

7.4

140

854

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

7.4

120

702

R43.8

ICD-10 Finland

Other and unspecified disturbances of smell and taste

3.4

7.4

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

7.4

189

1240

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.2

7.4

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

7.4

364

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.0

7.4

378

N05CF02

ATC

zolpidem; oral

1.3

7.4

507

3969

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.1

7.4

304

RK250, ,

NOMESCO Finland

3.7

7.3

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

7.3

138

840

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.3

200

1331

UJD10, ,

SPAT

2.1

7.3

338

K05

ICPC

Irregular heartbeat other

1.8

7.3

520

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

7.3

323

2360

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

7.3

3DX08, ,

NOMESCO Finland

+∞

7.3

4231

FHL

Sphenotomy

+∞

7.3

4733A

ICD-9 Finland

Chronic sinusitis, Sphenoidal

+∞

7.3

4230

FHL

Forehead cavity radical cutting and filling

+∞

7.3

M79.7

ICD-10 Finland

Fibromyalgia

1.9

7.3

421

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.3

528

R05DB20

ATC

other cough suppressants - combinations

1.6

7.3

148

920

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.0

7.2

105

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

7.2

141

867

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.2

305

2211

S62.6

ICD-10 Finland

Fracture of other finger

1.7

7.2

129

776

J01.3

ICD-10 Finland

Acute sphenoidal sinusitis

7.3

7.2

RK120, ,

NOMESCO Finland

7.3

7.2

A05

ICPC

Feeling ill

1.6

7.2

141

869

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

7.1

531

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

7.1

531

J01XB01

ATC

colistin; inhalant, parenteral

30.1

7.1

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

7.1

291

2096

B01AA03

ATC

warfarin; systemic

1.3

7.1

547

4344

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.1

350

2603

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.8

7.1

K08.80

ICD-10 Finland

Toothache NOS

1.5

7.0

239

1664

K07.60

ICD-10 Finland

Snapping jaw

1.7

7.0

131

796

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.0

947

8043

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.0

169

1094

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

7.0

367

2758

SDA03

NOMESCO Finland

Periodontal treatment

1.2

7.0

1254

10963

D11AH02

ATC

pimecrolimus; topical

7.0

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.3

7.0

232

PH2AE, ,

SPAT

2.2

7.0

245

DKW99

NOMESCO Finland

Other procedures for control of epistaxis

6.3

6.9

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

2.0

6.9

366

AA1AD

NOMESCO Finland

CT of head and brain

1.2

6.9

829

6950

XCK00

NOMESCO Finland

Perimetry

1.6

6.9

173

1131

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

13.8

6.9

ZFX00

NOMESCO Finland

Use of balloon dilatation

13.8

6.9

K59.0

ICD-10 Finland

Constipation

1.6

6.9

147

925

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

6.9

319

A29

ICPC

General symptom/complaint other

1.4

6.9

356

2670

WW200, ,

SPAT

1.3

6.8

704

5799

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.6

6.8

148

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

6.7

6.8

L29

ICPC

Musculoskeletal sympt/complt other

1.5

6.8

237

1659

ZXB87

NOMESCO Finland

Balloon dilation, paranasal sinuses

10.9

6.8

120

Kela drug reimbursment

Hypogammaglobulinaemia

10.9

6.8

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

10.9

6.8

XG420

NOMESCO Finland

Time-volume spirometry

10.9

6.8

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.8

483

3797

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

6.7

276

1990

SPAT1097

SPAT

Recording of ECG

1.3

6.7

430

3329

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

6.7

333

2482

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

2.8

6.7

110

50306

ICD-8 Finland

Chronic sinusitis, Pansinuitis chronica

22.5

6.7

50308

ICD-8 Finland

Chronic sinusitis, Alia definita

22.5

6.7

L13

ICPC

Hip symptom/complaint

1.3

6.7

528

4211

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

6.7

627

5110

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.7

168

1100

SPAT1301

SPAT

No procedures

1.2

6.7

925

7876

K85

ICPC

Elevated blood pressure

1.3

6.6

463

3629

SBA00

NOMESCO Finland

Microbiological examinations

2.0

6.6

372

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

6.6

508

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

6.6

164

1070

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

6.6

148

943

S51.0

ICD-10 Finland

Open wound of elbow

2.5

6.6

157

EMB10

NOMESCO Finland

Tonsillectomy

1.6

6.6

132

819

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.5

6.6

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

6.5

305

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.5

150

961

WX704

NOMESCO Finland

Intubation

1.5

6.5

231

1622

A13

ICPC

Concern/fear medical treatment

2.1

6.5

259

K63.5

ICD-10 Finland

Polyp of colon

2.0

6.5

313

XF404

NOMESCO Finland

Ambulatory ECG

1.4

6.5

251

1793

X57

ICD-10 Finland

Unspecified privation

2.0

6.5

327

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

6.5

327

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

6.5

193

1311

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

6.4

155

1004

Z00.0

ICD-10 Finland

General medical examination

1.3

6.4

554

4464

L08

ICPC

Shoulder symptom/complaint

1.3

6.4

656

5396

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

3.9

6.4

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.1

6.4

ZYC03

NOMESCO Finland

Remote contact, text-based

3.5

6.4

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

6.4

548

4411

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

70.0

6.4

C08CA01

ATC

amlodipine; oral

1.2

6.4

1208

10593

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

14.3

6.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

6.4

427

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

2.5

6.3

142

K57

ICD-10 Finland

Diverticular disease of intestine

2.0

6.3

323

R10.0

ICD-10 Finland

Acute abdomen

1.8

6.3

494

S51

ICD-10 Finland

Open wound of forearm

5.9

6.3

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

11.0

6.3

H05.0

ICD-10 Finland

Acute inflammation of orbit

11.0

6.3

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

9.3

6.3

SPAT1360

SPAT

Extensive global examination

1.5

6.3

190

1295

DNB00

NOMESCO Finland

External ethmoidectomy

+∞

6.2

4460B

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Polyarteritis nodosa[POLYARTERITIS NODOSA CUM INFILTRATIONE PULMONUM]

+∞

6.2

4AC06, ,

NOMESCO Finland

+∞

6.2

R05CB03

ATC

carbocisteine; oral

2.1

6.2

277

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

26.7

6.2

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.7

6.2

114

691

M10.9

ICD-10 Finland

Gout, unspecified

1.5

6.2

197

1355

B07.9

ICD-10 Finland

Verruca simplex

1.8

6.2

548

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

6.2

801

6762

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

1.8

6.2

482

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

6.2

100

586

A02BA03

ATC

famotidine; systemic

1.7

6.2

100

586

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.5

6.2

144

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

2.1

6.2

245

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

6.3

6.2

S01GX09

ATC

olopatadine; ophthalmic

1.9

6.2

375

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.8

6.1

505

SFA00

NOMESCO Finland

Small restoration

1.3

6.1

404

3141

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.7

6.1

121

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

3.2

6.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.1

675

5599

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

6.1

148

960

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

6.1

153

1000

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

6.1

535

S81.7

ICD-10 Finland

Multiple open wounds of lower leg

5.7

6.1

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.5

6.1

165

1097

V01AA02

ATC

grass pollen; parenteral

7.7

6.1

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

6.1

155

1017

F1246, ,

NOMESCO Finland

12.5

6.1

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

6.1

513

4124

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

6.1

321

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

6.1

500

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

8.6

6.0

ENC30

NOMESCO Finland

Plastic operation of pharynx

2.3

6.0

195

L08.0

ICD-10 Finland

Pyoderma

2.8

6.0

105

H57.1

ICD-10 Finland

Ocular pain

1.7

6.0

575

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

6.0

153

1004

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

6.0

127

798

D02

ICPC

Abdominal pain epigastric

1.5

6.0

159

1053

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.0

484

3867

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.9

6.0

350

R52.0

ICD-10 Finland

Acute pain

1.8

6.0

494

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

6.0

147

957

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

1089

1335

10.96

307.65

2.0

1.2

414.00

218.73

u/ml

2.59

1066

1196

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

280

39.64

307.65

1.6

1.3

1.90

0.69

u/ml

1.34

199

(4200892) Spirometry reversibility

854

1743

6.00

307.65

1.8

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

354

370

10.43

307.22

1.3

1.1

0.80

2.06

u/ml

1.81

248

166

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

323

11.00

296.75

1.2

1.0

2.99

5.41

u/ml

1.24

235

143

(3000492) Spirometry study

917

2594

4.32

292.67

1.9

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

304

282

11.61

286.32

1.2

1.0

1.16

1.35

u/ml

0.17

226

118

(3008401) Mugwort IgE Ab [Units/volume] in Serum

304

315

10.39

264.91

1.2

1.0

0.60

1.95

u/ml

1.20

203

113

(3013115) Eosinophils [#/volume] in Blood

2653

15777

3.17

241.62

7.8

6.0

0.34

0.19

e9/l

140.39

2370

13805

(3006315) Basophils [#/volume] in Blood

2548

15279

2.95

219.44

7.5

5.8

0.05

0.04

e9/l

32.46

2244

13194

(3001604) Monocytes [#/volume] in Blood

2542

15240

2.95

218.70

7.5

5.8

0.62

0.59

e9/l

10.86

2241

13165

(3023419) Bacteria identified in Sputum by Culture

269

313

9.16

214.34

3.5

2.1

—

(3019198) Lymphocytes [#/volume] in Blood

2577

15707

2.92

212.17

7.6

5.8

1.95

1.93

e9/l

0.22

2314

13871

(40760892) CBC W Ordered Manual Differential panel - Blood

2418

14371

2.82

206.84

7.8

6.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

940

3513

3.21

189.96

2.3

1.7

—

(3022096) Basophils/100 leukocytes in Blood

2314

13907

2.65

185.72

7.7

6.0

0.75

0.68

6.97

2221

12938

(3006504) Eosinophils/100 leukocytes in Blood

2360

14357

2.65

184.08

7.7

6.0

4.72

2.82

98.65

2266

13381

(3019069) Monocytes/100 leukocytes in Blood

2369

14445

2.65

183.78

7.9

6.3

8.42

8.71

5.79

2279

13494

(3023430) Cat dander IgE Ab [Units/volume] in Serum

216

232

9.80

182.61

1.2

1.0

3.32

4.26

u/ml

0.26

144

(3009445) Proteinase 3 Ab [Units/volume] in Serum

497

1247

4.43

180.98

1.6

1.5

15.03

19.20

u/ml

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2716

17864

2.75

177.86

9.7

9.2

4.31

4.07

e9/l

6.69

2400

15549

(3014133) Dog dander IgE Ab [Units/volume] in Serum

223

259

9.08

177.59

1.2

1.0

4.04

1.85

u/ml

1.36

162

104

(3018010) Neutrophils/100 leukocytes in Blood

2369

14627

2.60

176.02

7.6

5.9

56.88

57.15

0.54

2282

13668

(3002030) Lymphocytes/100 leukocytes in Blood

2392

14860

2.60

175.06

7.8

6.1

26.26

27.92

13.60

2301

13904

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

187

217

9.00

148.80

1.2

1.0

0.21

0.44

u/ml

0.46

106

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

403

996

4.40

148.71

1.9

1.5

337.14

320.00

titre

0.03

(3024139) IgG subclass 3 [Mass/volume] in Serum

198

252

8.23

146.21

1.8

1.3

0.31

0.41

g/l

3.30

154

169

(3027135) IgG subclass 1 [Mass/volume] in Serum

198

252

8.23

146.21

1.8

1.3

6.26

7.02

g/l

1.65

155

169

(3028192) IgG subclass 2 [Mass/volume] in Serum

198

252

8.23

146.21

1.8

1.3

3.02

2.96

g/l

0.15

153

169

(4062490) Immunoglobulin typing, IgG

196

254

8.07

142.53

1.8

1.3

—

(3042936) Bacteria identified in Isolate by Culture

966

4321

2.65

134.89

2.2

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

245

430

6.02

134.15

2.0

1.6

1.26

0.79

g/l

3.23

193

323

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

26.77

103.38

1.4

1.1

31.97

54.81

mg/l

0.94

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

215

445

5.06

97.95

1.7

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2979

23218

2.23

94.34

5.3

3.9

12.58

11.94

mm/h

1.71

2825

21458

(3000494) Fungus identified in Specimen by Culture

767

3616

2.40

91.93

1.9

1.4

—

(3021589) Normoblasts [#/volume] in Blood

2015

13764

1.97

90.43

10.6

9.4

0.00

e9/l

1.01

1603

11281

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

291

810

3.80

90.22

2.0

1.3

15.50

12.92

iu/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

148

240

6.37

87.47

4.5

3.5

—

(40768804) Tissue Pathology biopsy report

1866

12893

1.86

76.13

2.2

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

665

3220

2.29

73.49

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

659

3229

2.25

70.56

1.8

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

513

2269

2.45

69.44

2.9

2.7

10.09

10.75

g/l

3.28

485

2053

(40758558) Short blood count panel - Blood

1254

7838

1.89

68.33

7.3

6.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

856

4765

2.02

65.25

2.0

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

274

919

3.13

63.05

2.9

2.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1075

6534

1.89

62.93

1.8

1.7

0.96

1.28

mg/l

2.31

825

5024

(3036481) Cortisol [Moles/volume] in Serum or Plasma

550

2670

2.24

59.52

2.6

2.1

295.12

379.14

nmol/l

23.01

514

2444

(3028026) IgM [Mass/volume] in Serum or Plasma

412

1779

2.47

58.30

1.9

1.23

1.40

g/l

0.89

385

1609

(3023368) Bacteria identified in Blood by Culture

1272

8372

1.77

56.20

4.7

4.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3565

31770

2.55

55.58

19.5

13.6

23.53

24.30

mg/l

0.71

3078

24928

(44813793) Dust mix specific IgE antibody measurement

151

6.29

54.85

1.2

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

932

5698

1.84

52.02

1.6

1.5

2.50

2.47

g/l

0.11

603

3462

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2916

24539

1.76

48.72

8.4

7.5

75.89

78.29

u/l

1.70

2780

23156

(3018418) pH of Serum or Plasma

1323

9121

1.68

47.66

3.9

4.2

7.40

0.10

201

1767

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2015

15525

1.62

46.19

6.7

6.9

1.22

1.21

mmol/l

1.31

1777

13207

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1856

14092

1.61

44.61

5.9

6.1

1.21

mmol/l

0.39

1717

12860

(3002385) Erythrocyte distribution width [Ratio]

3136

27289

1.79

42.59

21.9

16.3

14.84

14.97

0.66

3106

26783

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2361

19114

1.60

42.39

3.3

2.7

—

(3037522) Nuclear Ab [Titer] in Serum

681

4030

1.84

41.13

1.4

1.3

489.31

556.96

titre

0.36

116

869

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1674

12573

1.58

40.90

2.5

2.2

78.04

77.74

nmol/l

0.16

1550

11270

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

565

3.12

40.21

1.4

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

202

737

2.84

39.82

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1235

8671

1.62

39.78

3.2

2.9

1172.56

1446.15

ng/l

1.53

1070

7413

(3013826) Glucose [Moles/volume] in Serum or Plasma

2290

18556

1.57

39.65

5.1

4.7

6.62

6.74

mmol/l

2.36

2185

17406

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

170

565

3.10

39.58

1.4

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.54

38.22

1.1

2.64

2.23

u/ml

0.05

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

217

841

2.67

38.08

1.5

1.6

0.24

g/l

0.26

210

794

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

177

625

2.92

37.04

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

774

2.71

36.78

2.0

1.9

10.72

11.61

mg/l

0.92

191

717

(40768797) Stomach Pathology biopsy report

693

4251

1.77

36.73

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2454

20375

1.56

36.70

4.7

4.3

282.04

1915.45

e6/l

2.22

282

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2054

16411

1.54

36.52

6.1

6.3

10.83

11.70

umol/l

3.57

1952

15595

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

281

1264

2.32

35.81

2.0

1.8

36.81

38.79

u/l

0.94

258

1101

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

218

877

2.57

35.47

1.5

1.6

1.20

1.17

g/l

0.88

211

830

(3019420) Tryptase [Mass/volume] in Serum or Plasma

140

5.22

35.17

1.4

1.6

8.51

9.93

ug/l

0.25

123

(3024561) Albumin [Mass/volume] in Serum or Plasma

1741

13511

1.52

34.83

4.9

35.30

35.57

g/l

1.24

1629

12592

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

6.37

33.75

1.2

1.1

4.40

7.62

u/ml

—

(3044889) 12 lead EKG panel

2644

22524

1.55

33.46

4.2

3.7

—

(3018095) Leukocytes [#/volume] in Urine

1460

10984

1.53

33.33

4.1

3.6

51.29

107.34

e6/l

3.75

1035

7794

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

782

5101

1.67

32.72

1.3

31.38

32.44

iu/ml

0.08

253

1640

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

892

6019

1.63

32.63

4.1

3.6

370.99

636.67

ng/l

0.77

693

4716

(36304419) Bacteria [Presence] in Urine

1171

8425

1.56

32.60

3.4

3.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1664

12930

1.50

32.25

3.1

2.8

113.31

141.55

ug/l

6.83

1548

11938

(3030467) Casts [#/volume] in Urine by Automated count

1193

8636

1.55

32.24

3.4

3.1

0.27

0.43

e6/l

4.42

888

6565

(3019550) Sodium [Moles/volume] in Serum or Plasma

3568

32976

2.05

31.74

20.0

15.8

139.70

139.72

mmol/l

0.09

3502

32165

(3002582) Erythrocytes [#/volume] in Urine

1282

9459

1.53

31.62

3.5

3.2

62.08

100.01

e6/l

0.73

966

7266

(3023103) Potassium [Moles/volume] in Serum or Plasma

3574

33090

2.05

31.02

20.1

15.9

3.94

3.98

mmol/l

17.47

3504

32221

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1642

12818

1.49

30.58

2.1

1.9

94.74

95.42

pmol/l

0.24

852

6697

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

744

4870

1.65

30.47

1.3

1.2

13.88

12.02

u/ml

0.27

272

1880

(3021440) Promyelocytes/100 leukocytes in Blood

434

2449

1.87

29.88

4.3

4.2

0.10

0.12

0.16

134

787

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

179

711

2.59

29.88

1.2

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2524

21533

1.49

29.60

4.7

4.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

118

376

3.21

29.52

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

50.42

29.36

1.6

1.9

55.23

33.86

umol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

373

3.20

29.24

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1109

8047

1.53

29.03

3.9

92.20

89.40

3.46

1087

7865

(3025159) Blasts/100 leukocytes in Blood

410

2299

1.88

28.75

4.4

4.2

0.06

0.24

0.81

109

643

(3017181) Myelocytes/100 leukocytes in Blood

446

2572

1.83

28.60

4.3

4.1

0.86

0.88

0.05

147

908

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2742

23899

1.51

28.07

4.2

3.8

14.86

14.77

pmol/l

1.22

2540

21709

(3022145) Colonoscopy Study observation

560

3469

1.72

28.04

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

414

2356

1.85

27.67

4.0

3.9

0.51

0.69

1.28

128

790

(3003327) Ova and parasites identified in Stool by Light microscopy

207

922

2.32

26.93

1.9

1.7

—

(3042631) Mycobacterium sp identified in Specimen

112

367

3.11

26.76

3.4

2.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

110

361

3.11

26.22

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

514

2.75

26.18

1.4

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1045

7631

1.51

26.01

2.4

2.1

2.94

2.92

mg/l

0.11

893

6506

(3014599) Egg white IgE Ab [Units/volume] in Serum

115

4.93

25.76

1.0

3.78

0.39

u/ml

0.67

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3317

30382

1.64

25.06

16.2

12.9

82.04

80.62

ml/min/173m2

3.80

2813

25128

(40761511) CBC panel - Blood by Automated count

3554

33203

1.86

24.64

15.7

12.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

4.88

24.56

4.8

3.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1802

14720

1.42

24.43

14.7

15.0

1.20

1.28

inr

3.70

481

4261

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

905

6488

1.52

24.35

1.3

1.2

2.06

1.75

u/ml

0.19

218

1707

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3192

29029

1.57

24.20

5.2

4.5

1.93

2.11

mu/l

1.19

2980

26539

(3027801) Oxygen [Partial pressure] in Arterial blood

545

3479

1.66

24.14

6.6

7.7

11.79

12.57

kpa

2.77

515

3323

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1494

11826

1.43

24.04

4.1

3.4

28.81

95.33

ng/l

1.05

1054

8177

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

544

3480

1.66

23.88

6.6

7.7

5.03

5.08

kpa

0.54

514

3323

(3000850) Epithelial cells [#/volume] in Urine

909

6550

1.51

23.79

2.8

2.6

4.45

5.26

e6/l

1.31

810

5879

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

322

1774

1.89

23.72

1.7

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

100

5.05

23.72

1.0

0.22

4.47

u/ml

0.48

(3015377) Calcium [Moles/volume] in Serum or Plasma

1339

10444

1.43

23.14

3.2

3.4

2.34

2.35

mmol/l

2.86

1202

9189

(3020874) Milk IgE Ab [Units/volume] in Serum

118

4.63

23.09

1.0

0.64

1.10

u/ml

0.25

(3022948) Iron [Moles/volume] in Serum or Plasma

703

4823

1.56

22.99

2.3

2.6

41.89

13.26

umol/l

0.48

650

4514

(3024891) Influenza virus A+B Ag [Presence] in Specimen

167

728

2.35

22.84

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

6.28

22.71

1.1

1.0

9.26

14.63

u/ml

0.45

(3003396) Base excess in Arterial blood by calculation

538

3477

1.64

22.60

6.6

7.7

1.30

0.92

mmol/l

1.59

411

2752

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1239

9566

1.43

22.49

2.3

2.1

145.17

231.77

u/l

5.16

1162

8984

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3618

34141

1.92

22.14

20.6

16.1

77.12

78.76

umol/l

2.75

3618

34130

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

712

4941

1.54

22.02

3.1

2.9

1.96

2.35

e6/l

0.74

375

2671

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

410

2.78

22.00

1.4

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

751

5277

1.53

21.92

3.0

2.7

0.66

1.05

e6/l

5.06

413

2984

(3048689) Calprotectin [Mass/mass] in Stool

546

3575

1.61

21.70

2.5

2.2

121.55

140.30

ug/g

0.87

455

2833

(3021601) Nitrite [Presence] in Urine by Test strip

1824

15138

1.39

21.49

5.1

4.7

0.00

estimate

0.80

323

2848

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

620

4195

1.57

21.42

2.3

2.7

22.16

23.30

1.19

534

3623

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

257

3.24

21.15

1.2

159.41

167.69

titre

0.04

(3009261) Glucose [Presence] in Urine by Test strip

1840

15330

1.38

20.99

3.8

3.6

0.00

estimate

1.23

313

2746

(3011397) Hemoglobin [Presence] in Urine by Test strip

955

7102

1.46

20.92

3.6

3.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

192

3.59

20.64

1.9

2.8

0.28

0.22

e9/l

1.60

172

(3035350) Ketones [Presence] in Urine by Test strip

1820

15170

1.38

20.54

3.8

3.5

0.00

estimate

1.47

336

3020

(3008536) Aspergillus sp Ab [Presence] in Serum

6.52

20.45

1.5

2.3

—

(3003338) MCHC [Mass/volume]

2980

27006

1.45

20.12

24.1

17.5

331.21

332.79

g/l

17.88

2960

26822

(3000060) B lymphocytes [#/volume] in Blood

5.55

20.06

1.6

2.3

244.00

177.81

e6/l

0.55

(3004789) Transferrin [Mass/volume] in Serum or Plasma

647

4479

1.53

20.06

2.3

2.6

2.35

2.29

g/l

1.95

604

4166

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1305

10335

1.40

19.92

3.3

3.2

31.32

37.16

u/l

1.41

1246

9827

(3015736) pH of Urine

1501

12174

1.38

19.81

3.4

3.2

5.74

5.81

0.41

117

910

(3016502) Oxygen saturation in Arterial blood

483

3138

1.62

19.71

6.9

8.2

95.47

95.83

0.70

463

3020

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

452

2892

1.64

19.62

2.4

32.08

55.68

u/l

0.81

382

2489

(3026493) Urate [Moles/volume] in Serum or Plasma

1098

8473

1.41

19.38

2.7

2739.48

4921.31

umol/l

1.22

964

7434

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3210

29578

1.50

19.32

6.1

5.7

40.42

39.84

mmol/mol

2.26

3012

27373

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

780

5664

1.47

19.09

2.7

3.1

2.45

mmol/l

0.31

688

4968

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

151

682

2.26

19.05

1.6

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

152

697

2.23

18.50

1.6

—

(3019060) Gas panel - Arterial blood

331

1981

1.73

18.45

3.7

5.0

—

(1002224) Polysomnography panel

235

1268

1.91

18.41

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

113

459

2.51

18.09

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

201

3.32

17.88

1.9

2.7

581.42

502.33

e6/l

0.56

173

(3009542) Hematocrit [Volume Fraction] of Blood

3709

35547

2.04

17.84

27.5

20.3

40.83

40.58

0.59

3517

33314

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

114

469

2.47

17.77

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

114

469

2.47

17.77

1.6

—

(3026782) Osmolality of Urine

840

6262

1.44

17.73

3.2

2.8

545.44

547.58

mosm/kgh2o

0.10

714

5384

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1231

9803

1.38

17.67

2.7

2.5

56.37

67.81

u/l

0.77

1142

9068

(3013139) Helicobacter pylori Ag [Presence] in Stool

337

2052

1.70

17.63

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

943

7184

1.41

17.62

1.6

1.5

20.03

20.60

nmol/l

0.61

839

6097

(3007461) Platelets [#/volume] in Blood

3710

35573

2.04

17.62

27.4

20.2

262.68

247.64

e9/l

36.51

3644

34682

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3600

34202

1.75

17.52

12.3

10.3

26.44

26.88

u/l

0.79

3502

32989

(3035941) MCH [Entitic mass]

3710

35590

2.03

17.32

27.3

20.1

30.25

30.39

5.61

3675

35086

(3024731) MCV [Entitic volume]

3710

35592

2.02

17.29

27.3

20.1

91.16

91.15

0.02

3675

35091

(3010813) Leukocytes [#/volume] in Blood

3710

35593

2.02

17.27

27.4

20.2

7.26

6.66

e9/l

42.45

3630

34589

(3026361) Erythrocytes [#/volume] in Blood

3710

35596

2.02

17.22

27.4

20.2

4.54

4.51

e12/l

2.91

3632

34598

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

292

1722

1.75

17.13

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

400

2.57

17.06

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

3710

35605

2.02

17.06

27.6

20.3

136.24

g/l

0.01

3677

35101

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

678

4894

1.47

16.89

1.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

444

2930

1.58

16.86

7.3

8.6

124.18

121.65

g/l

1.77

427

2849

(3014111) Lactate [Moles/volume] in Serum or Plasma

413

2685

1.60

16.70

6.7

7.3

1.23

1.37

mmol/l

2.57

400

2613

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

517

3567

1.52

16.03

2.7

6.34

8.81

umol/l

3.05

451

3128

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

212

3.10

15.78

1.7

1.4

32.00

20.15

u/ml

0.88

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

5.29

15.59

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

19.27

15.53

1.7

1.8

1.40

3.18

mg/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

210

3.08

15.39

1.7

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2382

21180

1.32

15.34

3.2

3.1

53.55

50.20

u/l

0.65

2243

19741

(3014576) Chloride [Moles/volume] in Serum or Plasma

553

3903

1.49

15.32

6.9

7.1

104.31

104.50

mmol/l

0.40

553

3897

(46235355) HIV 1 and 2 tests - Meaningful Use set

659

4818

1.44

15.21

1.6

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

389

2549

1.58

15.17

3.3

2.8

139.31

200.31

ng/l

4.41

344

2315

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

20.11

15.08

1.7

1.22

0.37

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

20.11

15.08

1.7

1.00

1.78

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

20.11

15.08

1.7

1.70

1.65

mg/l

—

(3011412) CD3 cells [#/volume] in Blood

295

2.71

15.05

1.9

2.6

1.38

1.14

e9/l

1.43

269

(36660697) Celiac disease serology panel - Serum

360

2330

1.60

14.78

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

405

2.43

14.71

1.0

1.1

1.42

1.55

g/l

2.29

364

(40768443) Skin Pathology biopsy report

233

1349

1.77

14.57

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

500

3501

1.49

14.36

2.6

1.70

1.75

0.53

447

3103

(3008152) Bicarbonate [Moles/volume] in Arterial blood

306

1923

1.64

14.16

5.5

7.1

24.36

24.47

mmol/l

0.20

290

1824

(3015171) Extractable nuclear Ab [Units/volume] in Serum

199

1109

1.84

14.12

1.3

1.2

0.45

1.19

u/ml

1.15

(3026389) Candida sp identified in Specimen by Organism specific culture

360

2.48

13.96

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

320

2.56

13.82

1.6

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

126

607

2.11

13.63

4.0

3.7

57.67

57.43

0.08

126

607

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1737

14943

1.29

13.54

2.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

320

2.53

13.32

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

110

510

2.19

13.12

1.6

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

678

5108

1.40

13.04

3.5

3.4

0.82

mmol/l

0.07

625

4806

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

222

2.82

12.83

1.7

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3308

31208

1.41

12.55

4.8

4.5

5.93

5.96

mmol/l

0.69

3063

28453

(3021447) Carbon dioxide [Partial pressure] in Venous blood

406

2818

1.49

12.10

4.1

3.8

5.88

5.82

kpa

0.63

392

2734

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

3.36

12.03

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

647

4898

1.39

12.01

1.9

2.1

29.83

29.91

0.12

631

4758

(3013005) Retinol [Moles/volume] in Serum or Plasma

110

3.57

11.98

2.1

1.6

1.84

1.97

umol/l

0.49

102

(3002032) Base excess in Venous blood by calculation

405

2819

1.49

11.90

4.1

3.8

2.19

1.85

mmol/l

1.14

348

2374

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

327

2177

1.55

11.85

1.8

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

162

897

1.84

11.78

2.9

3.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

158

873

1.84

11.57

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

377

2613

1.49

11.30

2.1

2.6

66.12

66.46

g/l

0.38

347

2386

(3014765) Yersinia sp identified in Stool by Organism specific culture

157

876

1.83

11.16

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

137

3.16

10.95

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

157

885

1.81

10.80

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

334

2287

1.50

10.62

3.4

2.9

4.64

4.63

kpa

0.02

320

2214

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

922

1.78

10.51

1.8

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

14.22

10.47

1.1

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

116

601

1.96

10.36

1.2

18.61

47.25

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

317

2.33

10.26

1.5

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

317

2169

1.50

10.11

1.9

2.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

160

928

1.76

10.02

2.1

2.2

0.07

0.01

g/l

0.84

151

859

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

484

3605

1.39

9.79

3.6

4.5

222.75

246.65

u/l

6.07

455

3410

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

147

2.95

9.75

1.1

1.0

10.60

10.25

iu/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

138

774

1.81

9.69

1.2

3.22

7.94

u/ml

1.40

137

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

243

1585

1.57

9.66

9.2

10.3

24.81

24.15

mmol/l

3.10

230

1548

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

404

2.13

9.63

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

107

3.29

9.56

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

296

2.32

9.53

1.5

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

136

765

1.81

9.46

1.2

2.45

6.17

u/ml

0.53

(3007930) Methemoglobin/Hemoglobin.total in Blood

202

1267

1.63

9.46

4.3

5.3

0.85

0.90

1.02

187

1185

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

318

2.26

9.32

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

365

2612

1.44

9.26

2.6

67.32

68.53

e9/l

0.30

250

1966

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

191

2.64

9.25

1.2

1.1

—

(3000991) Gas panel - Venous blood

358

2554

1.44

9.24

8.4

8.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

114

612

1.89

9.21

1.2

16.89

6.36

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

13.68

9.17

1.5

—

(3020891) Body temperature

193

1208

1.63

9.13

4.0

4.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3395

32487

1.37

9.08

5.2

4.9

2.76

mmol/l

0.07

3167

29993

(3039162) Centromere protein B Ab [Units/volume] in Serum

355

2.16

9.02

1.2

48.78

38.31

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

177

2.68

8.95

1.5

5.65

7.57

u/l

1.03

155

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

148

868

1.73

8.95

2.1

2.3

0.01

0.00

g/l

0.50

140

802

(3026008) Bacteria identified in Urine by Culture

1075

9053

1.26

8.94

3.0

3.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

200

1275

1.60

8.78

4.3

5.3

1.60

1.64

0.34

185

1191

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

858

1.73

8.77

2.1

2.3

0.00

g/l

-0.00

139

801

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

267

1818

1.50

8.74

3.7

3.5

1.59

1.75

mmol/l

0.36

203

1338

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

14.05

8.68

1.1

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1155

1.62

8.62

2.1

2.4

10.30

10.27

g/l

0.03

171

1035

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

252

1702

1.51

8.57

9.2

10.5

—

(3009343) pH of Capillary blood

274

1885

1.49

8.53

3.7

3.5

7.42

7.41

0.92

218

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.93

8.53

1.1

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

193

1241

1.58

8.19

2.2

2.3

7.26

7.33

g/l

0.25

182

1128

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

6.48

8.17

1.0

1.1

0.02

0.06

u/ml

0.65

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

275

1914

1.47

8.08

3.7

3.5

5.11

5.15

kpa

0.38

261

1814

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

192

1240

1.58

8.01

2.2

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

192

1240

1.58

8.01

2.2

2.3

4.12

3.64

g/l

1.03

180

1128

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

194

2.49

7.97

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

247

1690

1.49

7.91

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

1172

10076

1.23

7.91

3.2

7.61

7.75

mmol/l

0.50

999

8506

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

2.28

7.87

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

2.28

7.87

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

2.28

7.87

1.4

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

145

879

1.67

7.81

1.5

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1174

10106

1.23

7.81

2.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1059

1.61

7.77

2.1

2.4

1.38

0.98

g/l

0.31

155

922

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1338

11688

1.22

7.69

4.0

3.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

1165

1.58

7.67

2.2

2.4

2.92

2.95

g/l

0.14

170

1054

(3027273) Bicarbonate [Moles/volume] in Venous blood

217

1456

1.52

7.64

4.2

3.3

25.80

25.19

mmol/l

2.05

211

1407

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1009

8600

1.23

7.28

1.6

1.7

1.38

1.37

mmol/l

0.22

859

7215

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

192

1270

1.54

7.24

1.8

2.0

1.33

2.60

ug/l

1.17

168

1134

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

236

1634

1.47

7.15

2.6

2.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3325

31918

1.30

7.14

4.6

4.4

4.69

4.66

mmol/l

0.86

3106

29644

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

217

1478

1.50

7.13

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

187

2.42

7.08

1.6

1.3

476.67

186.15

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

154

973

1.61

7.08

2.0

2.2

36.90

37.75

g/l

1.04

142

861

(40759836) Histone Ab [Presence] in Serum by Immunoblot

212

2.33

7.06

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

212

2.33

7.06

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

125

750

1.69

7.04

1.5

1.6

12555.51

13627.19

e6/l

0.06

540

(3017732) Neutrophils [#/volume] in Blood

300

2180

1.41

7.01

2.5

3.1

5.73

5.24

e9/l

0.16

243

1763

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

213

2.32

6.99

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

196

2.36

6.86

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.30

6.84

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.30

6.84

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.30

6.84

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

786

6563

1.25

6.79

4.0

3.9

1.02

kg/l

0.61

983

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3301

31704

1.28

6.73

4.6

4.4

1.49

1.45

mmol/l

6.77

3074

29275

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

169

1106

1.55

6.70

1.6

1.7

—

(3022313) Gas panel - Capillary blood

204

1392

1.49

6.66

3.6

3.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

263

1886

1.42

6.63

3.7

3.1

133.20

129.00

g/l

2.36

258

1834

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

7.39

6.40

1.0

0.59

0.44

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

135

850

1.61

6.33

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

2.79

6.31

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3195

30622

1.25

6.28

4.1

4.0

1.28

1.31

mmol/l

1.47

2945

28057

(3044941) Cell count panel - Synovial fluid

503

1.79

6.23

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

252

1817

1.41

6.18

3.1

3.4

4.51

4.45

pmol/l

0.32

222

1612

(3004716) Salmonella sp identified in Stool by Organism specific culture

212

1483

1.45

6.13

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

169

2.38

6.12

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

105

2.78

6.04

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.17

6.00

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

640

1.67

5.89

2.6

2.2

130.34

129.20

g/l

0.15

457

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

625

1.68

5.88

6.7

5.6

283.57

3035.02

iu/ml

0.61

(3021901) Oxygen saturation in Capillary blood

527

1.74

5.88

3.2

2.8

—

(3047181) Lactate [Moles/volume] in Blood

150

988

1.54

5.83

5.0

6.2

1.21

1.30

mmol/l

0.79

131

869

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

904

7776

1.21

5.77

2.4

2.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

168

2.33

5.73

1.5

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

547

1.72

5.70

1.9

1.8

4.66

5.03

mmol/24h

0.55

479

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

139

906

1.55

5.67

1.5

1.6

0.11

1.18

iu/ml

0.61

178

(3012516) Albumin [Mass/volume] in Urine

1090

9562

1.19

5.62

3.3

510.41

302.44

mg/l

0.67

695

6122

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

464

1.76

5.46

1.3

1.2

3.33

5.01

u/ml

1.05

202

(3007919) Fasciola sp Ab [Titer] in Serum

16.03

5.41

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

350

2719

1.32

5.36

2.4

2.2

6.29

8.06

ug/l

1.37

313

2413

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

159

1081

1.49

5.35

2.0

2.3

191.11

710.24

ug/l

2.04

150

1027

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

188

2.19

5.24

1.3

1.2

—

(3039000) Anion gap in Blood

111

700

1.60

5.24

5.2

7.4

11.32

11.26

mmol/l

0.06

626

(3018572) Chloride [Moles/volume] in Blood

111

701

1.60

5.21

5.2

7.4

105.62

105.31

mmol/l

0.35

627

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

378

2983

1.30

5.16

2.2

0.22

0.21

g/l

0.63

358

2788

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

109

2.58

5.12

1.9

1650.00

29402.41

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

190

2.17

5.12

1.3

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

199

1426

1.42

5.10

3.0

2.6

1.21

1.22

0.07

199

1414

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

195

1393

1.42

5.09

3.1

2.6

0.63

0.64

0.22

195

1382

(3036489) Thrombin time

165

1146

1.46

5.01

2.0

23.35

21.46

0.68

144

1011

(3003740) Influenza virus B Ag [Presence] in Specimen

447

1.74

4.99

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.70

4.98

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

137

918

1.51

4.97

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

131

872

1.52

4.91

2.2

2.4

183.91

194.00

0.65

124

829

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

333

2611

1.30

4.79

1.5

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

250

1.97

4.77

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

446

1.72

4.76

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.73

4.75

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

577

1.63

4.73

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

330

2589

1.30

4.73

2.6

2.5

71.59

66.39

ml/min/173m2

1.66

125

1007

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

470

1.70

4.71

1.3

1.2

3.11

3.92

u/ml

0.29

153

(1616796) Gas panel - Central venous blood

106

681

1.57

4.67

4.2

3.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

299

2322

1.31

4.62

3.5

4.0

91.27

92.64

ng/l

0.09

256

2009

(3034860) Kappa light chains.free [Mass/volume] in Serum

145

999

1.47

4.62

2.2

3.6

62.93

59.50

mg/l

0.08

105

811

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.50

4.61

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.50

4.61

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.50

4.61

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

100

636

1.59

4.60

1.4

1.7

—

(3008898) HLA-B27 [Presence]

139

951

1.48

4.59

1.0

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

499

4133

1.24

4.56

5.3

6.2

1.03

mmol/l

0.12

468

3857

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

334

1.81

4.52

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

144

998

1.46

4.46

2.2

3.6

29.52

53.20

mg/l

2.16

104

810

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

256

1957

1.33

4.43

1.4

1.3

42.79

55.81

au/ml

0.51

118

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

140

967

1.46

4.42

2.2

3.6

3.32

2.63

ratio

0.13

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

134

918

1.48

4.41

2.2

2.5

3.78

3.58

g/l

0.68

129

868

(3012501) Base excess in Blood by calculation

108

710

1.54

4.33

4.2

4.4

2.27

2.60

mmol/l

0.69

476

(3029937) Albumin [Presence] in Urine by Test strip

927

8177

1.18

4.32

4.4

3.9

0.00

estimate

1.54

317

2710

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

151

2.20

4.30

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

151

2.20

4.30

1.5

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

302

2374

1.30

4.28

1.8

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

304

1.82

4.26

2.5

3.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

334

2665

1.28

4.22

2.4

2.2

13.08

13.02

nmol/l

0.05

293

2388

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

276

2150

1.31

4.19

2.4

21.48

24.22

au/ml

0.19

160

(3020682) Albumin/Creatinine [Ratio] in Urine

1122

10069

1.16

4.18

4.0

3.9

8.74

9.19

mg/mmol

0.12

711

6419

(3017143) Hepatitis C virus Ab [Presence] in Serum

413

3386

1.25

4.14

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

2.48

4.12

1.0

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

125

857

1.47

4.12

1.2

1410.00

1139.58

titre

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

890

1.46

4.12

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

330

2642

1.27

4.06

1.9

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

288

1.82

4.02

1.8

1.5

—

(3010421) pH of Blood

122

837

1.47

4.02

4.0

4.2

7.43

7.42

1.44

110

761

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

2.32

4.01

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

2.32

4.01

1.6

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

2.24

3.98

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

121

831

1.47

3.97

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

130

907

1.45

3.93

1.3

1.4

290.58

277.50

ug/g

0.29

518

(21494434) Karyotype in Bone marrow

299

1.78

3.87

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

234

1.89

3.87

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

119

2.28

3.86

1.6

2.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

7.29

3.85

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1082

9741

1.15

3.80

4.4

4.1

21.10

21.87

0.87

499

4691

(3021879) Hepatitis B virus core Ab [Presence] in Serum

278

2199

1.28

3.78

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

175

1298

1.36

3.74

2.1

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1329

12151

1.14

3.73

5.0

4.9

3.22

3.50

ug/l

0.10

1189

10937

(3019309) Folate [Moles/volume] in Red Blood Cells

662

5756

1.18

3.63

1.9

1.7

1123.79

1151.75

nmol/l

0.36

497

4336

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

569

1.54

3.63

1.1

1.2

253.30

285.53

u/ml

0.47

346

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.86

3.62

2.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

234

1.85

3.55

1.5

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

316

1.72

3.51

2.0

3.7

52.14

56.74

0.93

265

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.30

3.51

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.30

3.51

1.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

526

1.55

3.50

2.6

3.6

1.28

1.46

0.18

464

(3020779) Urea [Moles/volume] in Serum or Plasma

351

2884

1.24

3.48

6.3

7.8

9.60

10.05

mmol/l

0.61

328

2754

(3029075) Extractable nuclear Ab panel - Serum

2.48

3.46

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

163

1213

1.36

3.44

4.1

3.7

24.95

24.80

mmol/l

0.34

155

1119

(40760888) Immunoglobulin light chains.free panel - Serum

107

741

1.46

3.41

2.0

3.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

498

1.56

3.40

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

132

951

1.40

3.39

2.1

95.09

91.12

1.39

126

918

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

335

1.68

3.38

1.1

95.36

96.16

0.07

317

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

555

1.52

3.37

1.2

1.4

114.21

120.06

u/ml

0.17

104

(40767503) Oxygen content in Capillary blood by calculation

653

1.48

3.36

3.4

2.4

16.02

16.24

0.18

314

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.43

3.30

1.2

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

322

1.69

3.30

2.6

2.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.94

3.28

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

2.10

3.23

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

294

1.71

3.22

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

775

1.43

3.22

1.3

—

(3051651) Icteric interference index of Serum or Plasma

185

1.90

3.19

2.4

3.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

6.37

3.18

1.0

—

(3013512) EKG study

1037

9409

1.14

3.18

4.0

3.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

515

1.53

3.16

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

499

1.53

3.16

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

342

1.65

3.15

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

151

1.99

3.14

2.1

2.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

437

1.57

3.11

1.1

123.09

114.95

1.73

398

(3021788) Differential panel - Synovial fluid

559

1.50

3.08

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

119

859

1.40

3.06

1.2

88.46

91.49

titre

0.05

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

617

1.47

3.06

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

610

1.47

3.03

1.1

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

210

1654

1.29

3.01

2.9

2.8

0.14

0.29

e6/l

2.51

204

1612

(3011288) Drugs identified in Urine by Screen method

595

1.47

3.00

1.4

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

157

1190

1.33

2.98

1.9

1.7

—

(4035726) Immunohistochemistry procedure

345

2879

1.22

2.98

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

183

1.87

2.95

2.6

2.9

38.34

41.04

0.40

(1001926) Buprenorphine [Presence] in Urine by Screen method

101

714

1.43

2.94

1.2

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

907

8203

1.14

2.89

3.5

3.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.51

2.87

1.5

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

5.39

2.87

1.1

—

(3045142) Bone marrow Pathology biopsy report

383

1.58

2.85

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.30

2.83

1.1

1.2

—

(40761535) Cells panel - Urine sediment

305

2531

1.22

2.80

3.5

3.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

622

1.44

2.77

1.2

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

104

2.12

2.74

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

533

1.47

2.73

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

2.43

2.70

1.4

1.5

—

(3002256) Pathology report gross observation

487

4231

1.17

2.70

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

104

752

1.39

2.69

1.5

1.4

11.10

9.20

u/l

0.60

613

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

473

4103

1.17

2.68

1.4

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

3.76

2.67

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.76

2.67

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

1.87

2.66

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.39

2.63

1.4

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

150

1154

1.31

2.61

1.7

6.00

3.59

mg/l

1.19

126

836

(3050794) Legionella sp Ab [Presence] in Serum

3.61

2.57

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

330

1.58

2.57

3.4

4.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

238

1946

1.24

2.54

1.2

109.25

151.73

iu/ml

1.14

711

(3023410) Appearance of Cerebral spinal fluid

308

1.60

2.52

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

396

3403

1.18

2.52

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

157

1.85

2.52

1.0

1.6

2.25

1.70

u/field

0.43

112

(44816559) Phosphatidylethanol [Mass/volume] in Blood

585

1.43

2.50

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

462

1.48

2.48

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

151

1.86

2.46

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

151

1.86

2.46

1.5

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

203

1.73

2.44

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.55

2.44

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

434

3769

1.17

2.44

1.6

1.8

1.42

1.48

1.14

368

3318

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

204

1.72

2.40

1.1

1.0

—

(3024263) Appearance of Synovial fluid

167

1.80

2.40

1.3

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.01

2.40

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.21

2.37

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

136

1048

1.31

2.37

1.8

—

(3013637) Mi-2 Ab [Presence] in Serum

2.26

2.34

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.26

2.34

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.26

2.34

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.26

2.34

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

146

1141

1.29

2.30

1.3

1.4

28.94

30.14

iu/l

0.17

121

993

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

1.95

2.25

1.4

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

113

1.95

2.25

1.1

1.2

—

0.26

g/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

775

7050

1.12

2.22

3.2

3.0

0.63

0.77

ug/l

6.61

517

4666

(3045683) HLA typing for celiac disease panel - Blood or Tissue

179

1.74

2.22

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

179

1.74

2.22

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.69

2.20

1.8

1.9

—

(3017569) Oxygen content in Arterial blood

150

1.81

2.19

2.6

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

542

1.41

2.19

3.1

0.77

0.80

nmol/l

0.28

420

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.34

2.18

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

305

1.55

2.16

5.0

16.71

73.65

u/ml

1.50

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

101

1.99

2.15

2.6

3.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

251

1.60

2.12

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

116

890

1.31

2.12

1.8

1.7

357.70

300.87

mu/l

0.68

107

811

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.05

2.11

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

129

1006

1.29

2.09

2.0

1.8

40.92

41.85

nmol/l

0.19

123

969

(3042111) Morphology [Interpretation] in Bone marrow Narrative

574

1.38

2.06

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

114

879

1.31

2.02

1.2

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.05

2.01

1.3

43.60

32.16

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

163

1.72

1.98

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

147

1176

1.26

1.97

3.0

3.4

2416.03

3712.44

u/ml

0.16

123

1003

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.03

1.95

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

289

1.53

1.94

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

497

1.40

1.92

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

135

1075

1.27

1.89

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.16

1.88

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.31

1.87

1.5

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

491

1.39

1.87

1.2

—

(3027944) Amphetamines [Presence] in Urine

116

910

1.28

1.84

1.2

2.1

—

(3046861) Legionella sp Ag [Presence] in Urine

4.17

1.82

1.0

—

(3027008) Opiates [Presence] in Urine

118

929

1.28

1.82

1.2

2.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.05

1.80

1.1

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.76

1.79

1.1

1.3

—

(3028300) Cannabinoids [Presence] in Urine

118

933

1.27

1.77

1.2

2.1

—

(3016879) Cocaine [Presence] in Urine

109

855

1.28

1.74

1.2

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

382

3377

1.15

1.74

3.8

4.1

44.72

27.23

ug/l

0.23

317

2737

(3045414) Leukocytes [Presence] in Urine

173

1433

1.22

1.72

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

376

3324

1.15

1.72

3.6

3.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

290

1.49

1.71

1.6

1.3

1.24

1.43

nmol/l

0.62

263

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.30

1.70

2.1

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.91

1.69

1.6

1.4

8.31

9.04

ug/l

0.49

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

294

2557

1.16

1.69

3.3

4.1

1.23

mmol/l

0.12

263

2238

(3000764) Benzodiazepines [Presence] in Urine

116

922

1.27

1.68

1.2

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.10

1.65

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.10

1.65

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

212

1.56

1.65

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

220

1.55

1.64

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

326

1.45

1.64

4.1

6.1

7.24

7.21

mmol/l

0.02

274

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

1.69

1.64

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

269

1.49

1.63

2.4

1.8

6.54

8.08

umol/l

0.25

185

(3017704) Immunofixation for Urine

181

1.61

1.63

1.3

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

302

1.46

1.63

1.3

224177.21

110496.59

e6/l

0.22

218

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

120

1.75

1.62

1.2

1.9

55.67

161.31

umol/l

1.95

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

1.77

1.60

3.4

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

698

1.30

1.59

1.3

49.24

25.32

e6/l

0.28

538

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

698

1.30

1.59

1.3

1.4

307.06

993.75

e6/l

1.24

570

(3011985) Renin [Units/volume] in Plasma

404

1.39

1.59

1.4

33.25

56.63

mu/l

1.04

352

(3044290) Cell count panel - Cerebral spinal fluid

638

1.31

1.57

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

363

1.41

1.57

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

163

1357

1.21

1.57

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

176

1.60

1.54

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

177

1488

1.20

1.54

1.5

1.7

1.71

1.52

g/l

1.93

149

1280

(3028717) Thiamine [Mass/volume] in Blood

2.43

1.53

1.0

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.16

1.50

1.3

1.5

—

(3004451) EKG impression Narrative

163

1.60

1.46

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

219

1.51

1.46

1.5

1.6

86.45

85.54

umol/l

0.06

219

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.84

1.45

1.1

1.3

108.71

85.47

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

744

1.27

1.45

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

386

1.38

1.45

1.2

3.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

102

1.77

1.44

2.4

2.1

0.71

1.16

ug/l

0.96

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.73

1.43

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

387

1.37

1.43

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

311

1.42

1.43

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.31

1.43

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

380

1.37

1.40

1.5

51.77

58.00

0.43

242

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

562

1.30

1.40

2.2

3.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.08

1.38

1.4

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.94

1.38

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.94

1.36

1.0

12.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.34

0.0

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

799

1.25

1.32

1.3

1.2

600.32

522.31

mg/l

0.48

757

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

755

1.25

1.31

1.9

1.8

5.60

4.69

iu/l

0.29

274

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.50

1.30

1.2

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

403

1.34

1.30

1.2

1.3

7.54

7.25

mmol/l

0.29

350

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

193

1.51

1.29

1.6

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.78

1.28

2.2

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

1.53

1.25

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

175

1503

1.17

1.24

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

372

1.35

1.24

3.4

2.4

105.70

105.61

mmol/l

0.05

365

(3041354) Potassium [Moles/volume] in Venous blood

372

1.35

1.24

3.4

2.4

4.10

mmol/l

0.01

365

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.97

1.22

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

524

1.28

1.18

1.3

71.24

63.79

mmol/l

0.70

422

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

189

1.48

1.18

1.1

94.14

82.36

u/l

0.27

161

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

384

1.33

1.18

1.6

1.9

14.49

25.66

ug/l

2.49

378

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

182

1.49

1.15

1.1

16.35

17.70

u/l

0.10

151

(3035880) pH of Pleural fluid

174

1.50

1.15

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.73

1.15

1.1

88.50

86.37

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

697

1.24

1.14

1.2

3.89

3.79

mmol/l

0.24

653

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

134

1.57

1.14

1.2

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.90

1.12

1.1

1.4

105.27

106.13

0.03

(3012565) Volume of 24 hour Urine

152

1.52

1.08

1.7

2.6

2021.33

1886.87

0.25

136

(3000012) Reticulocyte production index

434

1.29

1.08

1.9

2.3

—

(3037121) Protein [Mass/volume] in Urine

130

1105

1.18

1.08

2.7

3.0

0.24

0.33

g/l

0.82

455

(3045424) Erythrocytes [Presence] in Urine

550

1.26

1.07

1.4

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

391

1.31

1.06

2.5

2.3

21.47

23.84

mg/l

0.11

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

253

1.39

1.06

1.9

2.0

1.50

2.01

u/field

0.38

(4281824) Cell count and differential, peritoneal fluid

314

0.67

1.06

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

289

1.35

1.03

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

204

1.42

1.02

7.1

6.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

360

1.31

1.00

1.4

1.3

23.76

26.96

u/l

0.26

293

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

1.00

4.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

378

1.30

0.99

1.4

2338.41

273.13

pmol/l

0.49

327

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

274

1.35

0.99

1.4

165.11

204.21

pmol/l

0.54

274

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.85

0.96

1.9

1.8

13.88

17.71

umol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

363

1.30

0.95

3.6

2.4

—

(3019977) pH of Arterial blood

166

1.45

0.94

2.3

2.6

7.44

7.42

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.22

0.93

1.7

2.1

1.29

1.71

mg/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.14

0.91

1.0

1.2

—

(3034426) Prothrombin time (PT)

110

1.55

0.90

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

1.38

0.88

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

181

0.61

0.87

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

369

1.28

0.86

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

229

1.36

0.86

1.2

—

3.44

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

700

6629

1.07

0.86

1.7

48552390.96

31750789.49

pmol/l

0.24

587

5496

(3013293) Extractable nuclear Ab [Presence] in Serum

1.82

0.85

1.9

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

388

1.27

0.85

1.6

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.94

0.84

2.7

2.5

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.78

0.84

1.4

1.3

100.62

131.78

ug/l

—

(3005033) Fetal Nuchal fold Thickness US

380

1.27

0.83

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

1.1

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.55

0.81

2.1

1.9

141.93

171.27

0.87

(3047352) Trisomy 18 risk [Likelihood] in Fetus

382

1.26

0.81

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

312

1.28

0.79

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.79

0.0

1.1

—

(40765096) Chromosome analysis panel by Banding

106

1.51

0.78

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

316

0.73

0.78

1.2

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

131

1.45

0.78

1.0

1.1

145.53

201.58

iu/ml

1.03

131

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

122

1067

1.15

0.77

2.8

3.2

0.38

0.34

u/ml

0.60

597

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

834

1.17

0.77

1.3

185.74

205.45

miu/ml

0.20

372

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

296

1.29

0.76

1.2

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

235

1.32

0.75

1.2

1.1

47.74

43.94

mg/l

0.12

191

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

702

0.82

0.75

2.6

3.6

50.95

759.28

u/ml

1.25

649

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

227

1.32

0.74

1.0

1.1

253.21

298.07

mg/l

0.59

195

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

325

1.26

0.73

1.1

61.42

64.01

u/l

0.15

293

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

110

0.54

0.72

1.2

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

507

1.21

0.71

2.0

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

407

1.23

0.71

1.1

1.0

1.61

3.56

u/ml

1.82

178

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.62

0.71

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.51

0.69

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

292

1.27

0.69

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.64

0.68

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.64

0.68

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.67

0.68

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

110

1.46

0.68

1.3

1.9

—

(3014891) Appearance of Pleural fluid

1.63

0.66

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.79

0.66

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

367

1.23

0.65

1.2

1.3

—

nmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

1.46

0.65

1.2

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

103

1.46

0.65

1.5

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

154

1.37

0.65

8.1

11.7

—

(3025130) Human papilloma virus identified in Specimen

341

1.23

0.63

1.6

1.8

—

(3024471) HLA-A [Type]

104

0.58

0.61

1.0

—

(3022621) pH of Urine by Test strip

224

2065

1.09

0.60

3.1

3.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.44

0.59

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

201

1.30

0.58

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

132

1.37

0.57

1.1

105.00

92.18

0.86

102

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.67

0.56

7.8

8.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

238

1.26

0.56

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

671

1.15

0.56

4.8

3.4

21.68

28.17

mg/l

0.89

401

(3014051) Protein [Presence] in Urine by Test strip

831

1.13

0.56

2.6

—

(4146454) Self-monitoring of blood glucose

363

0.80

0.55

2.5

2.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.62

0.55

1.8

1.4

70.57

75.32

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

417

0.81

0.55

1.6

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

124

0.64

0.54

1.0

1.4

—

2284600.00

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

515

1.17

0.54

1.1

3.57

1184.24

iu/ml

—

111

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

182

0.71

0.54

24.6

13.1

902.62

847.16

nmol/l

0.15

175

(21494890) Protein electrophoresis panel - 24 hour Urine

331

1.21

0.53

1.3

2.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

170

0.70

0.53

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

404

0.82

0.53

1.7

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.53

1.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.53

1.7

2.4

—

(21494755) Public health laboratory ask at order entry panel

306

2880

1.07

0.51

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

171

1.29

0.49

1.1

1.04

1.05

ratio

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

411

0.83

0.49

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

391

4110

0.95

0.48

4.4

4.5

32.65

32.26

0.28

283

2816

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

119

1.35

0.48

1.2

1.6

51.09

61.83

0.51

(3027923) C peptide [Moles/volume] in Serum or Plasma

181

1.27

0.48

1.3

1.32

1.21

nmol/l

0.16

133

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

166

0.72

0.47

1.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

420

0.83

0.47

1.6

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

411

1.17

0.46

5.4

6.5

11.35

11.80

mg/l

0.37

386

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

807

1.12

0.46

2.3

2.2

112.25

100.50

ug/min

0.12

489

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

138

1.31

0.45

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.59

0.45

1.8

1.5

16.54

12.32

g/l

—

(3045788) Cell count panel - Pleural fluid

292

1.20

0.45

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.28

0.45

1.4

1.6

—

(3008295) Osmolality of Serum or Plasma

330

0.82

0.44

1.1

1.3

279.25

279.76

mosm/kgh2o

0.05

255

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

311

1.19

0.44

2.8

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

405

0.84

0.44

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

405

0.84

0.44

1.6

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

448

0.85

0.44

4.2

5.3

342.58

363.47

umol/l

0.44

393

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

104

1.35

0.43

1.6

2.1

—

(3014271) Vancomycin [Susceptibility]

151

0.73

0.42

2.8

2.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

371

0.83

0.42

1.6

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

158

1.27

0.41

1.2

143.52

134.72

nmol/l

0.45

158

(3024928) Oxygen saturation in Venous blood

661

1.12

0.41

3.1

2.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.52

0.41

1.2

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.1

—

409.07

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

888

0.90

0.40

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.47

0.40

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

371

1.16

0.39

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

235

2218

1.06

0.39

1.5

1.7

—

(3024932) HLA-DR beta [Type]

102

0.69

0.39

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.39

0.0

1.0

—

79.33

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

752

1.11

0.37

2.0

2.1

4490.56

3988.48

u/l

0.06

304

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

113

0.71

0.37

1.8

1.3

2.48

4.58

umol/l

—

105

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

262

1.18

0.37

1.0

297.00

285.69

mg/l

0.35

238

(4034850) Laboratory test

109

1003

1.09

0.36

10.1

9.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

375

1.15

0.35

1.5

1.4

3369.62

1860.03

e6/l

0.79

272

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.35

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

858

8790

0.97

0.34

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.34

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.32

0.33

1.2

1.5

58.75

165.42

nmol/24h

0.88

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.67

0.32

5.8

7.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.35

0.31

1.3

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

347

0.86

0.30

1.5

0.28

0.30

nmol/l

0.05

273

(3028308) Erythrocytes [#/volume] in Pleural fluid

343

1.14

0.30

1.4

43917.19

84923.68

e6/l

0.65

209

(21494814) CD8 cells/100 lymphocytes in Specimen

129

1.24

0.30

1.5

2.1

—

(3022689) Creatine [Moles/volume] in Urine

1.29

0.30

2.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

325

1.14

0.29

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

497

1.11

0.28

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

195

1.18

0.28

1.1

4.67

7.33

nmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

461

1.11

0.27

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

462

1.11

0.26

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

462

1.11

0.26

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.67

0.25

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

197

1.17

0.25

1.2

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

463

1.10

0.25

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

377

1.12

0.25

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.74

0.24

5.8

7.5

—

(3020650) Glucose [Presence] in Urine

0.71

0.24

1.3

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

848

0.93

0.24

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

124

1.21

0.24

1.2

1.3

167.33

162.48

mmol/24h

0.07

124

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

152

1.19

0.23

4.4

3.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

443

4313

1.03

0.23

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

708

1.07

0.22

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

164

1569

1.05

0.21

4.1

3.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3016228) CD19 cells/100 cells in Blood

135

1.19

0.21

1.5

2.0

5.06

9.26

1.82

129

(3026470) Cobalt [Mass/volume] in Blood

220

0.86

0.21

2.0

2.31

3.04

ug/l

0.54

197

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

413

4025

1.03

0.21

8.0

6.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

672

1.07

0.21

2.2

1.9

1.00

0.83

nmol/l

1.36

565

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

102

0.78

0.21

1.3

1.2

—

17.31

—

(3042733) HLA Ab [Presence] in Serum

104

0.77

0.21

2.1

4.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

12.48

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

8.56

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

211

1.14

0.20

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

230

1.13

0.20

1.7

1.9

6.36

6.86

mmol/l

0.89

153

(1617658) Protocol used for examination of sentinel lymph nodes

240

1.13

0.20

1.0

—

(40768446) Kidney Pathology biopsy report

136

1.18

0.20

1.4

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

298

1.11

0.19

3.8

3.0

38.36

51.02

mg/l

0.15

232

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

118

1.19

0.19

1.2

1.0

—

(3049717) Cytology report of Urine Cyto stain

135

1292

1.05

0.18

2.5

2.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

175

1.14

0.18

1.1

1.15

1.13

u/l

—

(40768800) Prostate Pathology biopsy report

754

0.94

0.17

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.22

0.17

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

412

0.92

0.16

1.4

1.6

—

(3019225) pH of Specimen

334

3263

1.03

0.16

3.9

4.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.11

0.16

3.6

2.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

297

2898

1.03

0.16

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.10

0.15

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.21

0.15

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.14

0.15

1.1

1.4

—

(3015183) Erythrocyte sedimentation rate

161

0.87

0.15

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.80

0.14

1.7

1.9

—

(3006462) Nitrate [Presence] in Urine

150

1.13

0.14

2.6

3.4

—

(40768806) Pleura Pathology biopsy report

333

1.08

0.14

1.3

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.19

0.14

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

296

1.08

0.13

1.6

1.4

37.50

30.28

0.38

183

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

117

0.85

0.13

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

648

1.05

0.12

1.6

1.5

84.75

180.51

pmol/l

2.35

638

(3023183) Ammonium ion [Moles/volume] in Plasma

701

0.95

0.11

2.2

3.0

28.84

36.72

umol/l

2.27

636

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

147

0.88

0.11

1.9

2.4

—

(3004775) Volume in Urine collected for unspecified duration

269

1.08

0.11

2.5

2.2

735.89

624.97

0.67

182

(40768793) Breast Pathology biopsy report

669

0.96

0.11

1.2

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

850

1.04

0.10

3.5

3.0

1.49

1.57

mg/l

0.43

784

(3029396) Erythrocyte agglutination [Presence] in Blood

1.14

0.10

5.8

3.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

188

1921

0.98

0.10

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

126

1.11

0.09

1.1

1217.50

1557.25

miu/ml

0.58

126

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.11

0.09

3.7

5.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.11

0.09

1.2

1.8

74.82

154.43

ng/l

—

(3011648) Oxygen content in Venous blood

253

1.07

0.08

2.6

2.0

12.49

11.10

0.65

253

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

257

0.93

0.08

1.7

1.6

0.85

0.96

g/l

1.32

257

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

144

0.90

0.08

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

144

0.90

0.08

1.2

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

1.09

0.08

2.3

1.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.09

0.08

1.9

1.2

—

133.40

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.08

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.14

0.08

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

332

1.05

0.08

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.04

0.08

3.6

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.83

0.07

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.80

0.07

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1142

11483

0.99

0.07

2.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.04

0.07

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

108

1.11

0.07

3.2

7.1

24.03

24.72

mmol/l

0.25

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.84

0.06

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

770

0.97

0.06

1.8

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

192

0.94

0.05

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

1.10

0.05

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

232

0.95

0.05

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

251

0.96

0.04

1.0

46.53

43.95

ng/l

0.11

167

(3050129) First trimester maternal screen panel - Serum or Plasma

557

1.02

0.03

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

329

1.03

0.03

1.4

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

161

1.06

0.03

1.1

1.2

—

70.71

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

937

1.01

0.03

1.6

1.4

—

(40768441) Liver Pathology biopsy report

239

0.96

0.02

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

249

0.96

0.02

1.0

343.13

317.90

ng/l

0.21

170

(3006270) Folate [Moles/volume] in Blood

269

0.97

0.02

1.0

1.1

395.37

366.38

nmol/l

0.39

234

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

291

1.03

0.02

1.7

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

238

0.97

0.02

1.0

1.6

13.93

13.14

umol/l

0.19

225

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

248

0.97

0.02

1.0

761.87

703.06

ng/l

0.17

163

(3020876) Protein [Mass/time] in 24 hour Urine

348

0.98

0.01

1.9

2.5

1.78

1.30

g/24h

0.20

173

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

157

0.96

0.01

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

197

0.96

0.01

1.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

104

1.06

0.01

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

344

1.02

0.00

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

125

1.04

0.00

1.2

2.0

—

(3047189) Immunofixation for 24 hour Urine

165

0.97

0.00

1.3

1.5

—

(3016038) Potassium [Moles/volume] in Urine

195

0.97

0.00

1.1

36.69

35.04

mmol/l

0.16

171

(3012441) Differential panel - Pleural fluid

319

1.00

0.00

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

144

0.97

0.00

2.7

—

(3036180) Methadone [Presence] in Urine

106

1.04

0.00

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

266

2659

1.00

0.00

4.6

3.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

317

1.01

0.00

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

467

1.01

0.00

2.3

2.6

3.46

703.22

u/ml

0.68

457

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

207

1.01

0.00

1.4

1.65

1.57

g/l

0.42

207

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

4.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

-0.00

1.0

1.1

—

(3048879) Bone marrow aspiration report

0.98

-0.00

1.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.5

—

0.26

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

2.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

780

1.00

-0.00

5.2

4.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

3246.66

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.92

-0.00

1.1

1.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.91

-0.00

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.97

-0.00

6.8

7.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_EOSINOPHIL_SUGG and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.961 [0.87, 1.07]	0.46
Birth year	0.995 [0.99, 1.0]	0.228

During the follow-up period (1.1.1998 — 31.12.2019), 715 out of 6298 females with ASTHMA_EOSINOPHIL_SUGG died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.787 [0.72, 0.86]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.077

During the follow-up period (1.1.1998 — 31.12.2019), 1120 out of 7644 males with ASTHMA_EOSINOPHIL_SUGG died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_EOSINOPHIL_SUGG.

N-year risk	Females	Males
1	0.075%	0.185%
5	0.543%	1.05%
10	1.386%	2.583%
15	2.677%	5.032%
20	4.728%	8.745%

Relationships between endpoints

↥

Index endpoint: ASTHMA_EOSINOPHIL_SUGG – Suggestive for eosinophilic asthma

GWS hits: 30

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Suggestive for eosinophilic asthma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints